Home » Healthcare » Pharmaceuticals » Precision Medicine Market

Precision Medicine Market By Diagnostics (Genetic Testing, Biomarker-Based Testing); By Therapeutics (Targeted Therapies, Immunotherapies, Gene Therapies); By Technology (Big Data Analytics, AI and Machine Learning); By Application (Oncology, Cardiology, Neurology, Infectious Diseases); By End-User (Hospitals and Clinics, Research Institutions, Diagnostic Laboratories); By Mode of Action (Pharmacogenomics, Epigenomics); By Data Source (Genomic Data, Clinical Data); By Patient Involvement (Patient-Centric Precision Medicine, Physician-Driven Precision Medicine); By Region – Growth, Share, Opportunities & Competitive Analysis, 2024 – 2032

Price: $4999

Published: | Report ID: 11123 | Report Format : PDF
REPORT ATTRIBUTE DETAILS
Historical Period  2019-2022
Base Year  2023
Forecast Period  2024-2032
Precision Medicine Market Size 2023  USD 28915.2 Million
Precision Medicine Market, CAGR  13.20%
Precision Medicine Market Size 2032  USD 88255.9 Million

Market Insights

  • The global demand for Precision Medicine  was valued at USD 28915.2 million in 2023 and is expected to reach USD 88255.9 million in 2032, growing at a CAGR of 13.20% between 2024 and 2032.
  • The biomarker-based test is the fastest-growing category over the projection period, and the Genetic Testing segment is expected to increase at a CAGR of 7.96% over the projected period.
  •  Immunotherapies have become increasingly popular in the precision medicine sector.
  • AI and machine learning are the most rapidly growing segments of the precision medicine market.
  • In 2023, the oncology application dominated the global precision medicine market in terms of revenue share, while neurology is another important area in the market.
  • Hospitals and clinics are important investors, and research institutions are another high-demand sector in the precision medicine market.
  • Pharmacogenomics is the leading segment of the precision medicine market.
  • Genomic data is the most prominent segment in the precision medicine industry.
  • Patient-centric precision medicine is the largest stakeholder segment.
  • North America dominated the global Precision Medicine Market in 2023, accounting for 43% of revenue, while Asia Pacific is expected to be the fastest-growing region throughout the projected period.
  • The increase in genetic testing and companion diagnostics fuels market expansion.
  • Therapeutics are expensive, which limits market growth.

Precision Medicine Market

Design Element 2

Access crucial information at unmatched prices!

Request your free sample report today & start making informed decisions powered by Credence Research!

Download Free Sample

CTA Design Element 3

Executive Summary

Market Definition

The Precision Medicine Market refers to a specialized field of medicine that focuses on providing personalized and targeted treatments based on an individual’s unique characteristics, such as their genetic makeup, lifestyle, and environment. It aims to improve patient outcomes by tailoring medical interventions to specific patient subgroups, ultimately leading to more effective and efficient healthcare practices.

Market Overview

The global Precision Medicine Market has witnessed steady growth in recent years and is expected to grow at a CAGR of 13.20% between 2024 and 2032. The market was valued at USD 28915.2 million in 2023 and is expected to reach USD 88255.9 million in 2032.

The Precision Medicine Market is experiencing significant growth and is expected to continue expanding in the coming years. This market is driven by factors such as advancements in genomics, increasing prevalence of chronic diseases, and a growing focus on personalized healthcare. The market encompasses various segments, including diagnostics, therapeutics, and informatics. It offers opportunities for pharmaceutical companies, diagnostic companies, research institutions, and healthcare providers. Collaborations, partnerships, and investments in research and development characterize the market.

Overall, the Precision Medicine Market holds great potential in revolutionizing healthcare by providing tailored treatments and improving patient outcomes.

Segmentation by Diagnostics

  • The biomarker-based test is the fastest-growing category over the projection period, owing to rising demand for biomarkers in diagnosis and increased knowledge of biomarkers among researchers, which is positively impacting market growth.
  • The Genetic Testing segment is predicted to grow at a CAGR of 7.96% over the forecast period.

Segmentation by Therapeutics

  • Immunotherapies, which use the immune system to target and combat diseases such as cancer, have become increasingly popular in the precision medicine sector. They have demonstrated promising results and are undergoing extensive research and development.

Segmentation by Technology

  • AI and machine learning are the fastest-expanding segments of the precision medicine sector. AI and machine learning technologies are being used to evaluate massive volumes of data in precision medicine, allowing researchers and healthcare practitioners to make more accurate diagnoses, forecast patient outcomes, and create individualized treatment plans.

Segmentation by Application

  • The oncology application led the worldwide precision medicine market in revenue share in 2023 and is expected to increase at a rapid pace over the forecast period. The rising prevalence of cancer around the world is likely to drive up demand for precision medicine as a viable therapeutic method.
  • Neurology is another key segment in the Precision Medicine Market.

Segmentation by End-User

  • Hospitals and clinics are key stockholders because they play a critical role in patient care and precision medicine implementation. They have the facilities and competence to provide individualized treatments to patients.
  • On the other hand, research institutions are another high-demand area in the precision medicine industry. These institutes are dedicated to conducting research, clinical trials, and developing innovative medicines and technology to promote precision medicine. Their efforts inspire innovation and help create the future of precision medicine.

Segmentation by Mode of Action

  • Pharmacogenomics is the dominant segment of the precision medicine market. Pharmacogenomics is the study of how a person’s genetic composition effects their reaction to drugs.

Segmentation by Data Source

  • Genomic data is the most prominent segment in the precision medicine business. Genomic data is information derived from an individual’s DNA that can provide important insights into their genetic predispositions, illness risks, and potential treatment alternatives. Technological improvements have made genetic data more accessible and cost-effective, resulting in its widespread application in precision medicine research and clinical practice.

Segmentation by Patient Involvement

  • Patient-centric precision medicine is the largest shareholder segment in the precision medicine market. It emphasizes putting the patient at the center of their healthcare journey, including them in decision-making, and personalizing treatments to their requirements and preferences.

Segmentation by Region

  • North America dominated the global Precision Medicine Market in 2023, accounting for 43% of revenue
  • Asia Pacific is predicted to be the fastest-growing region throughout the projection period.
  • The rest of the world, including Latin America, the Middle East, and Africa, supplies the remaining demand for Precision Medicine.

In terms of revenue, North America held more than 43% of the total market value share in 2023 and is expected to continue its position in the future years. The increasing frequency of cancer, as well as the presence of prominent market players in the region, are projected to be key drivers driving market expansion in the region. Furthermore, demand for precision medicine is being driven mostly by positive government initiatives and increased investment in creating novel solutions for optimal illness management. For example, in September 2018, the National Institutes of Health (NIH) awarded a USD 28.6 million grant to three US-based genome centers. The funding enables these companies to generate genetic data from biosamples, which is an important component of precision medicine breakthroughs.

On the other hand, Asia Pacific is expected to rise rapidly throughout the projection period due to low-cost clinical trials of newly discovered diagnostic products and precision medicine. Furthermore, increased disposable income and an improving economy in developing countries such as India are likely to drive up demand for precision pharmaceuticals in the region. The region has various opportunities for expansion in the medical sector as a result of ongoing research and major investment in health care facilities and practices.

Key Highlights of the Report

The global Precision Medicine Market is segmented based on Diagnostics, Therapeutics, Technology, Application, End-User, Mode of Action, Data Source, Patient Involvement, and region. In 2023, the oncology application had the highest revenue share in the global precision medicine market, with pharmacogenomics dominating. In addition, the biomarker-based test category is expected to develop the fastest during the projection period, with genomic data being the most prominent section. In the precision medicine market, research institutions are also in high demand, with North America driving market expansion.

The market is being driven by advances in genomics and molecular diagnostics, an increased focus on personalized and targeted medicines, and an increasing demand for precision medicine in the treatment of chronic diseases. Furthermore, the primary market barriers are the high costs associated with precision medicine technology and treatments, limited payment policies and coverage for precision medicine, and ethical and privacy concerns linked to the use of patient data.

North America held more than 43% of the total market value share in 2023 and is expected to continue its position in the future years.  Furthermore, Asia Pacific expects profitable growth during the projection period due to low-cost clinical trials of newly developed diagnostic devices and precision medicine.

What Are The Main Drivers Of The Global Precision Medicine Market?

Advancements in genomics and molecular diagnostics have been a major driver in the growth of the Precision Medicine Market. The ability to analyze an individual’s genetic makeup and molecular characteristics has opened up new possibilities for personalized treatments. Additionally, the increasing focus on personalized and targeted therapies has driven the demand for precision medicine. By tailoring treatments to an individual’s unique characteristics, healthcare providers can improve patient outcomes and reduce the risk of adverse effects.

What Are The Major Challenges Faced By The Global Precision Medicine Market?

While the Precision Medicine Market shows great promise, several restraints need to be addressed. One of the main challenges is the high costs associated with precision medicine technologies and treatments. These advanced diagnostic tools and therapies can be expensive, limiting their accessibility for some patients. Additionally, limited reimbursement policies and coverage for precision medicine can pose a barrier to widespread adoption. Another important consideration is the ethical and privacy concerns related to the use of patient data. Safeguarding patient information and ensuring consent and privacy are key factors that need to be addressed to build trust and ensure the success of precision medicine initiatives.

What Are The Growth Opportunities In The Global Precision Medicine Market?

The Precision Medicine Market presents several opportunities for growth and development. One significant opportunity is the expansion of precision medicine into emerging markets. As healthcare systems in these regions continue to evolve, there is a growing demand for advanced and personalized healthcare solutions. Another opportunity lies in the development of companion diagnostics and targeted therapies. By identifying specific biomarkers and genetic variations, companion diagnostics can help healthcare professionals select the most appropriate treatment options for individual patients.

Market Drivers

Several factors drive the global Precision Medicine Market. The following are the key drivers of the global Precision Medicine Market:

Increase In Genetic Testing And Companion Diagnostics

Precision medicine regimens are prescribed only after a battery of diagnostic procedures to examine the patient’s genes for individual variability, genetic mutations, and variances. Therapeutics also includes the prescription of appropriate therapy/drug regimens to patients based on genetic testing results. Genetic testing is gaining popularity as a result of the availability of cancer screening tests, prenatal screening tests, and direct-to-consumer testing (DTC). Furthermore, genetic testing is critical to the development of companion diagnostics.

Companion diagnostics (CDx) are medical tests that are used to determine which patients are most likely to benefit from a certain therapeutic therapy. These tests enable the selection of tailored treatment, which contributes to the expansion of precision medicine adoption.

Market Restraints

The global Precision Medicine Market faces some challenges that may hinder its growth. These include the following:

Therapeutics Are Expensive

Precision medicine treatments are given following a thorough examination of the patient’s genetic makeup with diagnostic genetic tests. As a result, the precision medicine regimen is significantly more expensive overall. As a result, precision medicine access is limited for individuals with financial constraints or geographic places where the healthcare infrastructure is inadequately established to support such therapies. For example, the price of Novartis AG’s TECARTUS CAR T-cell therapy, which has been approved as a personalized medicine, ranges between USD 300,000 and USD 400,000; the price of AMVUTTRA (vutrisiran), which has been approved as a personalized medicine, ranges between USD 85,000 and USD 115,000 in the United States.

However, in the coming years, the costs of personalized medicines are expected to fall due to efforts by key players to offer therapies at lower prices, increased support from regulatory bodies and healthcare providers for increased adoption, and other factors, resulting in wider adoption.

Opportunities

The global Precision Medicine Market offers significant growth opportunities. These include the following:

Increasing Need For Cell And Gene Therapies

The need for cell and gene therapies has recently increased as a result of new discoveries. This is because cell and gene therapies have considerable promise to address a variety of areas. In many conditions when an effective medication is currently lacking. These indications mostly include chronic diseases in disciplines such as cancer, genetic disorders, and other uncommon diseases, among others. This is an opportunity for pharmaceutical and biotechnology businesses to invest in the research and marketing of innovative cell and gene therapies. Furthermore, cell and gene therapies provide a tailored therapeutic effect. As a result, they have also received widespread approval as customized medicine. In 2022, the FDA authorized five cell and gene treatments as personalized medicines. As a result, there is an increasing demand for cell and gene therapies due to the benefits they provide in terms of precision medicine.

Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!

Competitive Landscape

Key Players

The global Precision Medicine Market is highly competitive, with several key players. Some of the major players in the market and their market share are as follows:

  • Biocrates Life Sciences
  • TepnelPharma Services
  • Novartis, Qiagen
  • Quest Diagnostics
  • Menarini Silicon Biosystems
  • NanoString Technologies
  • Eagle Genomics
  • Pfizer
  • Intomics
  • Roche
  • Teva Pharmaceutical

These organizations prioritize product innovation, Service Provider expansion, and mergers and acquisitions to stay competitive.

The global Precision Medicine Market’s key players continually seek to stay ahead by offering new products and developments.

In December 2022, Roche announced the availability of a medicine for a rare auoimmune illness, neuromyelitis optica spectrum disorder (NMOSD), in India toward the end of 2023. This drug focuses on precision medicine.

In November 2022, BGI Genomics and the University of Pécs (UP) agreed to open a cooperative laboratory in Hungary. The collaborative lab will begin formal operations to speed the development of genetic sequencing and clinical diagnostic services, as well as to strengthen BGI Genomics’ and the UP’s revolutionary precision medicine advancements in Central and Eastern Europe.

In February 2023, Roche gained EC clearance to expand its Hemlibra (emicizumab) EU marketing license.

In June 2021, Phigenix, Inc. got US issue of the patent, which covers a unique diagnostic and therapeutic strategy for treating breast cancer that is resistant to conventional therapies. These innovations range from cancer diagnostics for precision medicine to new inhibitors of the PAX2 oncogene, as well as PAX2-mediated cancer cell survival and medication resistance.

Summary of Key Findings

  • Increasing need for cell and gene therapies.
  • Diagnostics, Therapeutics, Technology, Application, End-User, Mode of Action, Data Source, Patient Involvement, and Region segment of the market.
  • AI and machine learning are the fastest growing segments of the precision medicine industry.
  • Immunotherapies have become quite popular in the precision medicine sector.
  • North America is leading market growth.. The market is highly competitive, with key players including Biocrates Life Sciences, TepnelPharma Services, Novartis, Qiagen, Quest Diagnostics and Others.

Future Outlook

  • Continued growth and expansion
  • Advancements in genomics and personalized healthcare
  • Increasing prevalence of chronic diseases
  • Collaborations and partnerships
  • Investments in research and development
  • Potential to revolutionize healthcare and improve patient outcomes

How CXOs Can Benefit from the Credence Research Precision Medicine Market Report

  • Market Product Type and growth forecast: The report provides detailed estimates of the global Precision Medicine Market segmented by Diagnostics, Therapeutics, Technology, Application, End-User, Mode of Action, Data Source, Patient Involvement, and Region. It also includes forecasts for the market through 2032 based on key trends and drivers.
  • Market segmentation: The report segments the Precision Medicine Market by Diagnostics, Therapeutics, Technology, Application, End-User, Mode of Action, Data Source, Patient Involvement and Region. This segmentation provides CXOs with a granular understanding of the market and the opportunities in each segment.
  • Competitive Landscape: The report profiles the key players in the Precision Medicine Market and provides insights into their strategies, product offerings, and financial performance. This information can help CXOs to identify and assess their competition.
  • Key trends and drivers: The report identifies and analyzes the key trends and drivers shaping the Precision Medicine Market. This information can help CXOs make informed decisions about their investments and strategies.

CXOs can use the insights from the Credence Research Precision Medicine Market Report to:

  • Identify growth opportunities: The report can help CXOs identify new growth opportunities in the Precision Medicine Market. For example, it provides valuable insights and analysis that can assist them in making informed decisions and strategic plans for their businesses.
  • Make informed investment decisions: The report can help CXOs to make informed investment decisions about Precision Medicine. For example, it analyzes market trends, growth potential, and competitive landscape, allowing CXOs to assess the market’s attractiveness and identify investment opportunities.
  • Develop competitive strategies: The report can help CXOs develop competitive strategies for their Precision Medicine businesses. For example, the report identifies the key strategies that dark fiber providers are using to differentiate themselves from their competitors.
  • Track market developments: The report can help CXOs track market developments and stay ahead of the curve. For example, it provides insights into the latest trends and innovations in the Precision Medicine Market.

Overall, the Credence Research Precision Medicine Market Report is a valuable resource for CXOs who are looking to gain a deeper understanding of the market and identify opportunities for growth.

Segmentation

By Diagnostics:

  • Genetic Testing
  • Biomarker-Based Testing

By Therapeutics:

  • Targeted Therapies
  • Immunotherapies
  • Gene Therapies

By Technology:

  • Big Data Analytics
  • Artificial Intelligence (AI) and Machine Learning

By Application:

  • Oncology
  • Cardiology
  • Neurology
  • Infectious Diseases

By End-User:

  • Hospitals and Clinics
  • Research Institutions
  • Diagnostic Laboratories

By Mode of Action:

  • Pharmacogenomics
  • Epigenomics

By Data Source:

  • Genomic Data
  • Clinical Data

By Patient Involvement:

  • Patient-Centric Precision Medicine
  • Physician-Driven Precision Medicine

By Region

  • North America
    •  The U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • The U.K.
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • South-east Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Argentina
    • Rest of Latin America
  • Middle East & Africa
    • GCC Countries
    • South Africa
    • Rest of the Middle East and Africa

Table of Content
1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Scope
1.3. Market Introduction
2. Executive Summary
2.1. Market Snapshot: Global Precision Medicine Market
2.1.1. Global Precision Medicine Market, By Diagnostics
2.1.2. Global Precision Medicine Market, By Therapeutics
2.1.3. Global Precision Medicine Market, By Technology
2.1.4. Global Precision Medicine Market, By Application
2.1.5. Global Precision Medicine Market, By End-User
2.1.6. Global Precision Medicine Market, By Mode of Action
2.1.7. Global Precision Medicine Market, By Data Source
2.1.8. Global Precision Medicine Market, By Patient Involvement
2.1.9. Global Precision Medicine Market, By Region
2.2. Insights from Primary Respondents
3. Market Dynamics & Factors Analysis
3.1. Introduction
3.1.1. Global Precision Medicine Market Value, 2019-2032, (US$ Mn)
3.1.2. Y-o-Y Growth Trend Analysis
3.2. Market Dynamics
3.2.1. Precision Medicine Market Drivers
3.2.2. Precision Medicine Market Restraints
3.2.3. Precision Medicine Market Opportunities
3.2.4. Major Precision Medicine Industry Challenges
3.3. Growth and Development Patterns
3.4. Investment Feasibility Analysis
3.5. Market Opportunity Analysis
3.5.1. Diagnostics
3.5.2. Size
3.5.3. Technology
3.5.4. Application
3.5.5. Application
3.5.6. Mode of Action
3.5.7. Data Source
3.5.8. Patient Involvement
3.5.9. Geography
4. Market Competitive Landscape Analysis
4.1. Company Market Share Analysis, 2022
4.1.1. Global Precision Medicine Market: Company Market Share, Value 2022
4.1.2. Global Precision Medicine Market: Top 6 Company Market Share, Value 2022
4.1.3. Global Precision Medicine Market: Top 3 Company Market Share, Value 2022
4.2. Global Precision Medicine Market: Company Revenue Share Analysis, 2022
4.3. Company Assessment Metrics, 2022
4.3.1. Stars
4.3.2. Emerging Leaders
4.3.3. Pervasive Players
4.3.4. Participants
4.4. Startups/ SMEs Assessment Metrics, 2022
4.4.1. Progressive Companies
4.4.2. Responsive Companies
4.4.3. Dynamic Companies
4.4.4. Starting Blocks
4.5. Strategic Development
4.5.1. Acquisition and Mergers
4.5.2. New Patient Involvement Launch
4.5.3. Regional Expansion
4.5.4. Partnerships
4.6. Key Player Patient Involvement Matrix
4.7. Potential for New Players in the Global Precision Medicine Market
5. Premium Insights
5.1. STAR (Situation, Task, Action, Results) Analysis
5.2. Porter’s Five Forces Analysis
5.2.1. Threat of New Entrants
5.2.2. Bargaining Power of Buyers/Consumers
5.2.3. Bargaining Power of Suppliers
5.2.4. Threat of Substitute Diagnostics
5.2.5. Intensity of Competitive Rivalry
5.3. PESTEL Analysis
5.3.1. Political Factors
5.3.2. Economic Factors
5.3.3. Social Factors
5.3.4. Technological Factors
5.3.5. Environmental Factors
5.3.6. Legal Factors
5.4. Key Market Trends
5.4.1. Demand Side Trends
5.4.2. Supply Side Trends
5.5. Value Chain Analysis
5.6. Application Analysis
5.6.1. Research and development in the global market
5.6.2. Patent Analysis
5.6.3. Emerging technologies and their potential disruption to the market
5.7. Consumer Behaviour Analysis
5.7.1. Consumer Preferences and Expectations
5.7.2. Factors Influencing Consumer Buying Decisions
5.7.2.1. North America
5.7.2.2. Europe
5.7.2.3. Asia Pacific
5.7.2.4. Latin America
5.7.2.5. Middle East and Africa
5.7.3. Consumer Pain Points
5.8. Analysis and Recommendations
5.9. Adjacent Market Analysis
6. Market Positioning of Key Players, 2022
6.1. Company market share of key players, 2022
6.2. Competitive Benchmarking
6.3. Market Positioning of Key Vendors
6.4. Geographical Presence Analysis
6.5. Major Strategies Adopted by Key Players
6.5.1. Key Strategies Analysis
6.5.2. Mergers and Acquisitions
6.5.3. Partnerships
6.5.4. Patient Involvement Launch
6.5.5. Geographical Expansion
6.5.6. Others
7. Impact Analysis of COVID 19 and Russia – Ukraine War on Precision Medicine Market
7.1. Ukraine-Russia War Impact
7.1.1. Uncertainty and Economic Instability
7.1.2. Supply chain disruptions
7.1.3. Regional market shifts
7.1.4. Shift in government priorities
7.2. COVID-19 Impact Analysis
7.2.1. Supply Chain Disruptions
7.2.2. Demand Fluctuations
7.2.3. Shift in Patient Involvement Mix
7.2.4. Reduced Oncology Activity
7.2.5. Regional Impact Analysis
7.2.5.1. North America
7.2.5.2. Europe
7.2.5.3. Asia Pacific
7.2.5.4. Latin America
7.2.5.5. Middle East and Africa
8. Global Precision Medicine Market, By Diagnostics
8.1. Global Precision Medicine Market Overview, by Diagnostics
8.1.1. Global Precision Medicine Market Revenue Share, By Diagnostics, 2023 Vs 2032 (in %)
8.2. Genetic Testing
8.2.1. Global Precision Medicine Market, By GENETIC TESTING, By Region, 2019-2032 (US$ Mn)
8.2.2. Market Dynamics for GENETIC TESTING
8.2.2.1. Drivers
8.2.2.2. Restraints
8.2.2.3. Opportunities
8.2.2.4. Trends
8.3. Biomarker-Based Testing
8.3.1. Global Precision Medicine Market, By Biomarker-Based Testing, By Region, 2019-2032 (US$ Mn)
8.3.2. Market Dynamics for Biomarker-Based Testing
8.3.2.1. Drivers
8.3.2.2. Restraints
8.3.2.3. Opportunities
8.3.2.4. Trends
9. Global Precision Medicine Market, By Therapeutics
9.1. Global Precision Medicine Market Overview, By Therapeutics
9.1.1. Global Precision Medicine Market Revenue Share, By Therapeutics, 2023 Vs 2032 (in %)
9.2. Targeted Therapies
9.2.1. Global Precision Medicine Market, By Targeted Therapies, By Region, 2019-2032 (US$ Mn)
9.2.2. Market Dynamics for Targeted Therapies
9.2.2.1. Drivers
9.2.2.2. Restraints
9.2.2.3. Opportunities
9.2.2.4. Trends
9.3. Immunotherapies
9.3.1. Global Precision Medicine Market, By Immunotherapies, By Region, 2019-2032 (US$ Mn)
9.3.2. Market Dynamics for Immunotherapies
9.3.2.1. Drivers
9.3.2.2. Restraints
9.3.2.3. Opportunities
9.3.2.4. Trends
9.4. Gene Therapies
9.4.1. Global Precision Medicine Market, By Gene Therapies, By Region, 2019-2032 (US$ Mn)
9.4.2. Market Dynamics for Gene Therapies
9.4.2.1. Drivers
9.4.2.2. Restraints
9.4.2.3. Opportunities
9.4.2.4. Trends
10. Global Precision Medicine Market, By Technology
10.1. Global Precision Medicine Market Overview, by Technology
10.1.1. Global Precision Medicine Market Revenue Share, By Technology, 2023 Vs 2032 (in %)
10.2. Big Data Analytics
10.2.1. Global Precision Medicine Market, By Big Data Analytics, By Region, 2019-2032 (US$ Mn)
10.2.2. Market Dynamics for Big Data Analytics
10.2.2.1. Drivers
10.2.2.2. Restraints
10.2.2.3. Opportunities
10.2.2.4. Trends
10.3. Artificial Intelligence (AI) and Machine Learning
10.3.1. Global Precision Medicine Market, By Artificial Intelligence (AI) and Machine Learning, By Region, 2019-2032 (US$ Mn)
10.3.2. Market Dynamics for Artificial Intelligence (AI) and Machine Learning
10.3.2.1. Drivers
10.3.2.2. Restraints
10.3.2.3. Opportunities
10.3.2.4. Trends
11. Global Precision Medicine Market, By Application
11.1. Global Precision Medicine Market Overview, by Application
11.1.1. Global Precision Medicine Market Revenue Share, By Application, 2023 Vs 2032 (in %)
11.2. Oncology
11.2.1. Global Precision Medicine Market, By Oncology, By Region, 2019-2032 (US$ Mn)
11.2.2. Market Dynamics for Oncology
11.2.2.1. Drivers
11.2.2.2. Restraints
11.2.2.3. Opportunities
11.2.2.4. Trends
11.3. Cardiology
11.3.1. Global Precision Medicine Market, By Cardiology, By Region, 2019-2032 (US$ Mn)
11.3.2. Market Dynamics for Cardiology
11.3.2.1. Drivers
11.3.2.2. Restraints
11.3.2.3. Opportunities
11.3.2.4. Trends
11.4. Neurology
11.4.1. Global Precision Medicine Market, By Neurology, By Region, 2019-2032 (US$ Mn)
11.4.2. Market Dynamics for Neurology
11.4.2.1. Drivers
11.4.2.2. Restraints
11.4.2.3. Opportunities
11.4.2.4. Trends
11.5. Infectious Diseases
11.5.1. Global Precision Medicine Market, By Infectious Diseases, By Region, 2019-2032 (US$ Mn)
11.5.2. Market Dynamics for Infectious Diseases
11.5.2.1. Drivers
11.5.2.2. Restraints
11.5.2.3. Opportunities
11.5.2.4. Trends
12. Global Precision Medicine Market, By End-User
12.1. Global Precision Medicine Market Overview, By End-User
12.1.1. Global Precision Medicine Market Revenue Share, By End-User, 2023 Vs 2032 (in %)
12.2. Hospitals and Clinics
12.2.1. Global Precision Medicine Market, By Hospitals and Clinics, By Region, 2019-2032 (US$ Mn)
12.2.2. Market Dynamics for Hospitals and Clinics
12.2.2.1. Drivers
12.2.2.2. Restraints
12.2.2.3. Opportunities
12.2.2.4. Trends
12.3. Research Institutions
12.3.1. Global Precision Medicine Market, By Research Institutions, By Region, 2019-2032 (US$ Mn)
12.3.2. Market Dynamics for Research Institutions
12.3.2.1. Drivers
12.3.2.2. Restraints
12.3.2.3. Opportunities
12.3.2.4. Trends
12.4. Diagnostic Laboratories
12.4.1. Global Precision Medicine Market, By Diagnostic Laboratories, By Region, 2019-2032 (US$ Mn)
12.4.2. Market Dynamics for Diagnostic Laboratories
12.4.2.1. Drivers
12.4.2.2. Restraints
12.4.2.3. Opportunities
12.4.2.4. Trends
13. Global Precision Medicine Market, By Mode of Action
13.1. Global Precision Medicine Market Overview, by Mode of Action
13.1.1. Global Precision Medicine Market Revenue Share, By Mode of Action, 2023 Vs 2032 (in %)
13.2. Pharmacogenomics
13.2.1. Global Precision Medicine Market, By Pharmacogenomics, By Region, 2019-2032 (US$ Mn)
13.2.2. Market Dynamics for Pharmacogenomics
13.2.2.1. Drivers
13.2.2.2. Restraints
13.2.2.3. Opportunities
13.2.2.4. Trends
13.3. Epigenomics
13.3.1. Global Precision Medicine Market, By Epigenomics, By Region, 2019-2032 (US$ Mn)
13.3.2. Market Dynamics for Epigenomics
13.3.2.1. Drivers
13.3.2.2. Restraints
13.3.2.3. Opportunities
13.3.2.4. Trends
14. Global Precision Medicine Market, By Data Source
14.1. Global Precision Medicine Market Overview, by Data Source
14.1.1. Global Precision Medicine Market Revenue Share, By Data Source, 2023 Vs 2032 (in %)
14.2. GENOMIC DATA
14.2.1. Global Precision Medicine Market, By GENOMIC DATA, By Region, 2019-2032 (US$ Mn)
14.2.2. Market Dynamics for GENOMIC DATA
14.2.2.1. Drivers
14.2.2.2. Restraints
14.2.2.3. Opportunities
14.2.2.4. Trends
14.3. CLINICAL DATA
14.3.1. Global Precision Medicine Market, By CLINICAL DATA, By Region, 2019-2032 (US$ Mn)
14.3.2. Market Dynamics for CLINICAL DATA
14.3.2.1. Drivers
14.3.2.2. Restraints
14.3.2.3. Opportunities
14.3.2.4. Trends
15. Global Precision Medicine Market, By Patient Involvement
15.1. Global Precision Medicine Market Overview, by Patient Involvement
15.1.1. Global Precision Medicine Market Revenue Share, By Patient Involvement, 2023 Vs 2032 (in %)
15.2. Patient-Centric Precision Medicine
15.2.1. Global Precision Medicine Market, By Patient-Centric Precision Medicine, By Region, 2019-2032 (US$ Mn)
15.2.2. Market Dynamics for Patient-Centric Precision Medicine
15.2.2.1. Drivers
15.2.2.2. Restraints
15.2.2.3. Opportunities
15.2.2.4. Trends
15.3. Physician-Driven Precision Medicine
15.3.1. Global Precision Medicine Market, By Physician-Driven Precision Medicine, By Region, 2019-2032 (US$ Mn)
15.3.2. Market Dynamics for Physician-Driven Precision Medicine
15.3.2.1. Drivers
15.3.2.2. Restraints
15.3.2.3. Opportunities
15.3.2.4. Trends
16. Global Precision Medicine Market, By Region
16.1. Global Precision Medicine Market Overview, by Region
16.1.1. Global Precision Medicine Market, By Region, 2023 Vs 2032 (in%)
16.2. Diagnostics
16.2.1. Global Precision Medicine Market, By Diagnostics, 2019-2032 (US$ Mn)
16.3. Size
16.3.1. Global Precision Medicine Market, By Therapeutics, 2019-2032 (US$ Mn)
16.4. Technology
16.4.1. Global Precision Medicine Market, By Technology, 2019-2032 (US$ Mn)
16.5. Application
16.5.1. Global Precision Medicine Market, By Application, 2019-2032 (US$ Mn)
16.6. End-User
16.6.1. Global Precision Medicine Market, By End-User, 2019-2032 (US$ Mn)
16.7. Mode of Action
16.7.1. Global Precision Medicine Market, By Mode of Action, 2019-2032 (US$ Mn)
16.8. Data Source
16.8.1. Global Precision Medicine Market, By Data Source, 2019-2032 (US$ Mn)
16.9. Patient Involvement
16.9.1. Global Precision Medicine Market, By Patient Involvement, 2019-2032 (US$ Mn)
17. North America Precision Medicine Market Analysis
17.1. Overview
17.1.1. Market Dynamics for North America
17.1.1.1. Drivers
17.1.1.2. Restraints
17.1.1.3. Opportunities
17.1.1.4. Trends
17.2. North America Precision Medicine Market, by Diagnostics, 2019-2032(US$ Mn)
17.2.1. Overview
17.2.2. SRC Analysis
17.3. North America Precision Medicine Market, By Therapeutics, 2019-2032(US$ Mn)
17.3.1. Overview
17.3.2. SRC Analysis
17.4. North America Precision Medicine Market, by Technology, 2019-2032(US$ Mn)
17.4.1. Overview
17.4.2. SRC Analysis
17.5. North America Precision Medicine Market, by Application, 2019-2032(US$ Mn)
17.5.1. Overview
17.5.2. SRC Analysis
17.6. North America Precision Medicine Market, By End-User, 2019-2032(US$ Mn)
17.6.1. Overview
17.6.2. SRC Analysis
17.7. North America Precision Medicine Market, by Mode of Action, 2019-2032(US$ Mn)
17.7.1. Overview
17.7.2. SRC Analysis
17.8. North America Precision Medicine Market, by Data Source, 2019-2032(US$ Mn)
17.8.1. Overview
17.8.2. SRC Analysis
17.9. North America Precision Medicine Market, by Patient Involvement, 2019-2032(US$ Mn)
17.9.1. Overview
17.9.2. SRC Analysis
17.10. North America Precision Medicine Market, by Country, 2019-2032(US$ Mn)
17.10.1. North America Precision Medicine Market, by Country, 2023 Vs 2032 (in%)
17.10.2. U.S.
17.10.3. Canada
17.10.4. Mexico
18. Europe Precision Medicine Market Analysis
18.1. Overview
18.1.1. Market Dynamics for North America
18.1.1.1. Drivers
18.1.1.2. Restraints
18.1.1.3. Opportunities
18.1.1.4. Trends
18.2. Europe Precision Medicine Market, by Diagnostics, 2019-2032(US$ Mn)
18.2.1. Overview
18.2.2. SRC Analysis
18.3. Europe Precision Medicine Market, By Therapeutics, 2019-2032(US$ Mn)
18.3.1. Overview
18.3.2. SRC Analysis
18.4. Europe Precision Medicine Market, by Technology, 2019-2032(US$ Mn)
18.4.1. Overview
18.4.2. SRC Analysis
18.5. Europe Precision Medicine Market, by Application, 2019-2032(US$ Mn)
18.5.1. Overview
18.5.2. SRC Analysis
18.6. Europe Precision Medicine Market, By End-User, 2019-2032(US$ Mn)
18.6.1. Overview
18.6.2. SRC Analysis
18.7. Europe Precision Medicine Market, by Mode of Action, 2019-2032(US$ Mn)
18.7.1. Overview
18.7.2. SRC Analysis
18.8. Europe Precision Medicine Market, by Data Source, 2019-2032(US$ Mn)
18.8.1. Overview
18.8.2. SRC Analysis
18.9. Europe Precision Medicine Market, by Patient Involvement, 2019-2032(US$ Mn)
18.9.1. Overview
18.9.2. SRC Analysis
18.10. Europe Precision Medicine Market, by Country, 2019-2032 (US$ Mn)
18.10.1. Europe Precision Medicine Market, by Country, 2023 Vs 2032 (in%)
18.10.2. UK
18.10.3. France
18.10.4. Germany
18.10.5. Italy
18.10.6. Spain
18.10.7. Benelux
18.10.8. Russia
18.10.9. Rest of Europe
19. Asia Pacific Precision Medicine Market Analysis
19.1. Overview
19.1.1. Market Dynamics for North America
19.1.1.1. Drivers
19.1.1.2. Restraints
19.1.1.3. Opportunities
19.1.1.4. Trends
19.2. Asia Pacific Precision Medicine Market, by Diagnostics, 2019-2032(US$ Mn)
19.2.1. Overview
19.2.2. SRC Analysis
19.3. Asia Pacific Precision Medicine Market, By Therapeutics, 2019-2032(US$ Mn)
19.3.1. Overview
19.3.2. SRC Analysis
19.4. Asia Pacific Precision Medicine Market, by Technology, 2019-2032(US$ Mn)
19.4.1. Overview
19.4.2. SRC Analysis
19.5. Asia Pacific Precision Medicine Market, by Application, 2019-2032(US$ Mn)
19.5.1. Overview
19.5.2. SRC Analysis
19.6. Asia Pacific Precision Medicine Market, By End-User, 2019-2032(US$ Mn)
19.6.1. Overview
19.6.2. SRC Analysis
19.7. Asia Pacific Precision Medicine Market, by Mode of Action, 2019-2032(US$ Mn)
19.7.1. Overview
19.7.2. SRC Analysis
19.8. Asia Pacific Precision Medicine Market, by Data Source, 2019-2032(US$ Mn)
19.8.1. Overview
19.8.2. SRC Analysis
19.9. Asia Pacific Precision Medicine Market, by Patient Involvement, 2019-2032(US$ Mn)
19.9.1. Overview
19.9.2. SRC Analysis
19.10. Asia Pacific Precision Medicine Market, by Country, 2019-2032 (US$ Mn)
19.10.1. Asia Pacific Precision Medicine Market, by Country, 2023 Vs 2032 (in%)
19.10.2. China
19.10.3. Japan
19.10.4. India
19.10.5. South Korea
19.10.6. South East Asia
19.10.7. Rest of Asia Pacific
20. Latin America Precision Medicine Market Analysis
20.1. Overview
20.1.1. Market Dynamics for North America
20.1.1.1. Drivers
20.1.1.2. Restraints
20.1.1.3. Opportunities
20.1.1.4. Trends
20.2. Latin America Precision Medicine Market, by Diagnostics, 2019-2032(US$ Mn)
20.2.1. Overview
20.2.2. SRC Analysis
20.3. Latin America Precision Medicine Market, By Therapeutics, 2019-2032(US$ Mn)
20.3.1. Overview
20.3.2. SRC Analysis
20.4. Latin America Precision Medicine Market, by Technology, 2019-2032(US$ Mn)
20.4.1. Overview
20.4.2. SRC Analysis
20.5. Latin America Precision Medicine Market, by Application, 2019-2032(US$ Mn)
20.5.1. Overview
20.5.2. SRC Analysis
20.6. Latin America Precision Medicine Market, By End-User, 2019-2032(US$ Mn)
20.6.1. Overview
20.6.2. SRC Analysis
20.7. Latin America Precision Medicine Market, by Mode of Action, 2019-2032(US$ Mn)
20.7.1. Overview
20.7.2. SRC Analysis
20.8. Latin America Precision Medicine Market, by Data Source, 2019-2032(US$ Mn)
20.8.1. Overview
20.8.2. SRC Analysis
20.9. Latin America Precision Medicine Market, by Patient Involvement, 2019-2032(US$ Mn)
20.9.1. Overview
20.9.2. SRC Analysis
20.10. Latin America Precision Medicine Market, by Country, 2019-2032 (US$ Mn)
20.10.1. Latin America Precision Medicine Market, by Country, 2023 Vs 2032 (in%)
20.10.2. Brazil
20.10.3. Argentina
20.10.4. Rest of Latin America
21. Middle East Precision Medicine Market Analysis
21.1. Overview
21.1.1. Market Dynamics for North America
21.1.1.1. Drivers
21.1.1.2. Restraints
21.1.1.3. Opportunities
21.1.1.4. Trends
21.2. Middle East Precision Medicine Market, by Diagnostics, 2019-2032(US$ Mn)
21.2.1. Overview
21.2.2. SRC Analysis
21.3. Middle East Precision Medicine Market, By Therapeutics, 2019-2032(US$ Mn)
21.3.1. Overview
21.3.2. SRC Analysis
21.4. Middle East Precision Medicine Market, by Technology, 2019-2032(US$ Mn)
21.4.1. Overview
21.4.2. SRC Analysis
21.5. Middle East Precision Medicine Market, by Application, 2019-2032(US$ Mn)
21.5.1. Overview
21.5.2. SRC Analysis
21.6. Middle East Precision Medicine Market, By End-User, 2019-2032(US$ Mn)
21.6.1. Overview
21.6.2. SRC Analysis
21.7. Middle East Precision Medicine Market, by Mode of Action, 2019-2032(US$ Mn)
21.7.1. Overview
21.7.2. SRC Analysis
21.8. Middle East Precision Medicine Market, by Data Source, 2019-2032(US$ Mn)
21.8.1. Overview
21.8.2. SRC Analysis
21.9. Middle East Precision Medicine Market, by Patient Involvement, 2019-2032(US$ Mn)
21.9.1. Overview
21.9.2. SRC Analysis
21.10. Middle East Precision Medicine Market, by Country, 2019-2032 (US$ Mn)
21.10.1. Middle East Precision Medicine Market, by Country, 2023 Vs 2032 (in%)
21.10.2. UAE
21.10.3. Saudi Arabia
21.10.4. Rest of Middle East
22. Africa Precision Medicine Market Analysis
22.1. Overview
22.1.1. Market Dynamics for North America
22.1.1.1. Drivers
22.1.1.2. Restraints
22.1.1.3. Opportunities
22.1.1.4. Trends
22.2. Africa Precision Medicine Market, by Diagnostics, 2019-2032(US$ Mn)
22.2.1. Overview
22.2.2. SRC Analysis
22.3. Africa Precision Medicine Market, By Therapeutics, 2019-2032(US$ Mn)
22.3.1. Overview
22.3.2. SRC Analysis
22.4. Africa Precision Medicine Market, by Technology, 2019-2032(US$ Mn)
22.4.1. Overview
22.4.2. SRC Analysis
22.5. Africa Precision Medicine Market, by Application, 2019-2032(US$ Mn)
22.5.1. Overview
22.5.2. SRC Analysis
22.6. Africa Precision Medicine Market, By End-User, 2019-2032(US$ Mn)
22.6.1. Overview
22.6.2. SRC Analysis
22.7. Africa Precision Medicine Market, by Mode of Action, 2019-2032(US$ Mn)
22.7.1. Overview
22.7.2. SRC Analysis
22.8. Africa Precision Medicine Market, by Data Source, 2019-2032(US$ Mn)
22.8.1. Overview
22.8.2. SRC Analysis
22.9. Africa Precision Medicine Market, by Patient Involvement, 2019-2032(US$ Mn)
22.9.1. Overview
22.9.2. SRC Analysis
22.10. Africa Precision Medicine Market, by Country, 2019-2032 (US$ Mn)
22.10.1. Middle East Precision Medicine Market, by Country, 2023 Vs 2032 (in%)
22.10.2. South Africa
22.10.3. Egypt
22.10.4. Rest of Africa
23. Company Profiles
23.1. Biocrates Life Sciences
23.1.1. Company Overview
23.1.2. Patient Involvements/Gene Therapies Portfolio
23.1.3. Geographical Presence
23.1.4. SWOT Analysis
23.1.5. Financial Summary
23.1.5.1. Market Revenue and Net Profit (2019-2022)
23.1.5.2. Business Segment Revenue Analysis
23.1.5.3. Geographical Revenue Analysis
23.2. TepnelPharma Services
23.3. Novartis
23.4. Qiagen
23.5. Quest Diagnostics
23.6. Menarini Silicon Biosystems
23.7. NanoString Technologies
23.8. Eagle Genomics
23.9. Pfizer
23.10. Intomics
23.11. Roche
23.12. Teva Pharmaceutical
24. Research Methodology
24.1. Research Methodology
24.2. Phase I – Secondary Research
24.3. Phase II – Data Modelling
24.3.1. Company Share Analysis Model
24.3.2. Revenue Based Modelling
24.4. Phase III – Primary Research
24.5. Research Limitations
24.5.1. Assumptions

List of Figures
FIG. 1 Global Precision Medicine Market: Research Methodology
FIG. 2 Market Size Estimation – Top Down & Bottom up Approach
FIG. 3 Global Precision Medicine Market Segmentation
FIG. 4 Global Precision Medicine Market, by Diagnostics, 2022 (US$ Mn)
FIG. 5 Global Precision Medicine Market, By Therapeutics, 2022 (US$ Mn)
FIG. 6 Global Precision Medicine Market, by Technology, 2022 (US$ Mn)
FIG. 7 Global Precision Medicine Market, by Data Trasnfer Speed, 2022 (US$ Mn)
FIG. 8 Global Precision Medicine Market, By End-User, 2022 (US$ Mn)
FIG. 9 Global Precision Medicine Market, by Mode of Action, 2022 (US$ Mn)
FIG. 10 Global Precision Medicine Market, by Data Source, 2022 (US$ Mn)
FIG. 11 Global Precision Medicine Market, by Patient Involvement, 2022 (US$ Mn)
FIG. 12 Global Precision Medicine Market, by Geography, 2022 (US$ Mn)
FIG. 13 Attractive Investment Proposition, by Diagnostics, 2022
FIG. 14 Attractive Investment Proposition, By Therapeutics, 2022
FIG. 15 Attractive Investment Proposition, by Technology, 2022
FIG. 16 Attractive Investment Proposition, by Application, 2022
FIG. 17 Attractive Investment Proposition, By End-User, 2022
FIG. 18 Attractive Investment Proposition, by Mode of Action, 2022
FIG. 19 Attractive Investment Proposition, by Data Source, 2022
FIG. 20 Attractive Investment Proposition, by Patient Involvement, 2022
FIG. 21 Attractive Investment Proposition, by Geography, 2022
FIG. 22 Global Market Share Analysis of Key Precision Medicine Market Manufacturers, 2022
FIG. 23 Global Market Positioning of Key Precision Medicine Market Manufacturers, 2022
FIG. 24 Global Precision Medicine Market Value Contribution, By Diagnostics, 2022 & 2030 (Value %)
FIG. 25 Global Precision Medicine Market, by Genetic Testing, Value, 2019-2032 (US$ Mn)
FIG. 26 Global Precision Medicine Market, by Biomarker-Based Testing, Value, 2019-2032 (US$ Mn)
FIG. 27 Global Precision Medicine Market Value Contribution, By Therapeutics, 2022 & 2030 (Value %)
FIG. 28 Global Precision Medicine Market, by Targeted Therapies, Value, 2019-2032 (US$ Mn)
FIG. 29 Global Precision Medicine Market, By Immunotherapies, Value, 2019-2032 (US$ Mn)
FIG. 30 Global Precision Medicine Market, by Gene Therapies, Value, 2019-2032 (US$ Mn)
FIG. 31 Global Precision Medicine Market Value Contribution, By Technology, 2022 & 2030 (Value %)
FIG. 32 Global Precision Medicine Market, by Big Data Analytics, Value, 2019-2032 (US$ Mn)
FIG. 33 Global Precision Medicine Market, by Artificial Intelligence (AI) and Machine Learning, Value, 2019-2032 (US$ Mn)
FIG. 34 Global Precision Medicine Market Value Contribution, By Application, 2022 & 2030 (Value %)
FIG. 35 Global Precision Medicine Market, by Oncology, Value, 2019-2032 (US$ Mn)
FIG. 36 Global Precision Medicine Market, by Cardiology, Value, 2019-2032 (US$ Mn)
FIG. 37 Global Precision Medicine Market, by Neurology, Value, 2019-2032 (US$ Mn)
FIG. 38 Global Precision Medicine Market, by Infectious Diseases, Value, 2019-2032 (US$ Mn)
FIG. 39 Global Precision Medicine Market Value Contribution, By End-User, 2022 & 2030 (Value %)
FIG. 40 Global Precision Medicine Market, by Hospitals and Clinics, Value, 2019-2032 (US$ Mn)
FIG. 41 Global Precision Medicine Market, by Research Institutions, Value, 2019-2032 (US$ Mn)
FIG. 42 Global Precision Medicine Market, by Diagnostic Laboratories, Value, 2019-2032 (US$ Mn)
FIG. 43 Global Precision Medicine Market Value Contribution, By Mode of Action, 2022 & 2030 (Value %)
FIG. 44 Global Precision Medicine Market, by Pharmacogenomics, Value, 2019-2032 (US$ Mn)
FIG. 45 Global Precision Medicine Market, by Epigenomics, Value, 2019-2032 (US$ Mn)
FIG. 46 Global Precision Medicine Market Value Contribution, By Data Source, 2022 & 2030 (Value %)
FIG. 47 Global Precision Medicine Market, by GENOMIC DATA, Value, 2019-2032 (US$ Mn)
FIG. 48 Global Precision Medicine Market, by CLINICAL DATA, Value, 2019-2032 (US$ Mn)
FIG. 49 Global Precision Medicine Market, by Patient-Centric Precision Medicine, Value, 2019-2032 (US$ Mn)
FIG. 50 Global Precision Medicine Market, by Physician-Driven Precision Medicine, Value, 2019-2032 (US$ Mn)
FIG. 51 North America Precision Medicine Market, 2019-2032 (US$ Mn)
FIG. 52 U.S. Precision Medicine Market, 2019-2032 (US$ Mn)
FIG. 53 Canada Precision Medicine Market, 2019-2032 (US$ Mn)
FIG. 54 Mexico Precision Medicine Market, 2019-2032 (US$ Mn)
FIG. 55 Europe Precision Medicine Market, 2019-2032 (US$ Mn)
FIG. 56 Germany Precision Medicine Market, 2019-2032 (US$ Mn)
FIG. 57 France Precision Medicine Market, 2019-2032 (US$ Mn)
FIG. 58 U.K. Precision Medicine Market, 2019-2032 (US$ Mn)
FIG. 59 Italy Precision Medicine Market, 2019-2032 (US$ Mn)
FIG. 60 Spain Precision Medicine Market, 2019-2032 (US$ Mn)
FIG. 61 Benelux Precision Medicine Market, 2019-2032 (US$ Mn)
FIG. 62 Russia Precision Medicine Market, 2019-2032 (US$ Mn)
FIG. 63 Rest of Europe Precision Medicine Market, 2019-2032 (US$ Mn)
FIG. 64 Asia Pacific Precision Medicine Market, 2019-2032 (US$ Mn)
FIG. 65 China Precision Medicine Market, 2019-2032 (US$ Mn)
FIG. 66 Japan Precision Medicine Market, 2019-2032 (US$ Mn)
FIG. 67 India Precision Medicine Market, 2019-2032 (US$ Mn)
FIG. 68 South Korea Precision Medicine Market, 2019-2032 (US$ Mn)
FIG. 69 South-East Asia Precision Medicine Market, 2019-2032 (US$ Mn)
FIG. 70 Rest of Asia Pacific Precision Medicine Market, 2019-2032 (US$ Mn)
FIG. 71 Latin America Precision Medicine Market, 2019-2032 (US$ Mn)
FIG. 72 Brazil Precision Medicine Market, 2019-2032 (US$ Mn)
FIG. 73 Argentina Precision Medicine Market, 2019-2032 (US$ Mn)
FIG. 74 Rest of Latin America Precision Medicine Market, 2019-2032 (US$ Mn)
FIG. 75 Middle East Precision Medicine Market, 2019-2032 (US$ Mn)
FIG. 76 UAE Precision Medicine Market, 2019-2032 (US$ Mn)
FIG. 77 Saudi Arabia Precision Medicine Market, 2019-2032 (US$ Mn)
FIG. 78 Rest of Middle East Precision Medicine Market, 2019-2032 (US$ Mn)
FIG. 79 Africa Precision Medicine Market, 2019-2032 (US$ Mn)
FIG. 80 South Africa Precision Medicine Market, 2019-2032 (US$ Mn)
FIG. 81 Egypt Precision Medicine Market, 2019-2032 (US$ Mn)
FIG. 82 Rest of Africa Precision Medicine Market, 2019-2032 (US$ Mn)

List of Tables
TABLE 1 Market Snapshot: Global Precision Medicine Market
TABLE 2 Global Precision Medicine Market: Market Drivers Impact Analysis
TABLE 3 Global Precision Medicine Market: Market Restraints Impact Analysis
TABLE 4 Global Precision Medicine Market, by Competitive Benchmarking, 2022
TABLE 5 Global Precision Medicine Market, by Geographical Presence Analysis, 2022
TABLE 6 Global Precision Medicine Market, by Key Strategies Analysis, 2022
TABLE 7 Global Precision Medicine Market, by Genetic Testing, By Region, 2019-2032 (US$ Mn)
TABLE 8 Global Precision Medicine Market, by Genetic Testing, By Region, 2024-2032 (US$ Mn)
TABLE 9 Global Precision Medicine Market, by Biomarker-Based Testing, By Region, 2019-2032 (US$ Mn)
TABLE 10 Global Precision Medicine Market, by Biomarker-Based Testing, By Region, 2024-2032 (US$ Mn)
TABLE 11 Global Precision Medicine Market, by Targeted Therapies, By Region, 2019-2032 (US$ Mn)
TABLE 12 Global Precision Medicine Market, by Targeted Therapies, By Region, 2024-2032 (US$ Mn)
TABLE 13 Global Precision Medicine Market, By Immunotherapies, By Region, 2019-2032 (US$ Mn)
TABLE 14 Global Precision Medicine Market, By Immunotherapies, By Region, 2024-2032 (US$ Mn)
TABLE 15 Global Precision Medicine Market, by Gene Therapies, By Region, 2019-2032 (US$ Mn)
TABLE 16 Global Precision Medicine Market, by Gene Therapies, By Region, 2024-2032 (US$ Mn)
TABLE 17 Global Precision Medicine Market, By Big Data Analytics, By Region, 2019-2032 (US$ Mn)
TABLE 18 Global Precision Medicine Market, By Big Data Analytics, By Region, 2024-2032 (US$ Mn)
TABLE 19 Global Precision Medicine Market, By Artificial Intelligence (AI) and Machine Learning), By Region, 2019-2032 (US$ Mn)
TABLE 20 Global Precision Medicine Market, By Artificial Intelligence (AI) and Machine Learning, By Region, 2024-2032 (US$ Mn)
TABLE 21 Global Precision Medicine Market, by Oncology, By Region, 2019-2032 (US$ Mn)
TABLE 22 Global Precision Medicine Market, by Oncology, By Region, 2024-2032 (US$ Mn)
TABLE 23 Global Precision Medicine Market, by Cardiology, By Region, 2019-2032 (US$ Mn)
TABLE 24 Global Precision Medicine Market, by Cardiology, By Region, 2024-2032 (US$ Mn)
TABLE 25 Global Precision Medicine Market, by Neurology, By Region, 2019-2032 (US$ Mn)
TABLE 26 Global Precision Medicine Market, by Neurology, By Region, 2024-2032 (US$ Mn)
TABLE 27 Global Precision Medicine Market, by Infectious Diseases, By Region, 2019-2032 (US$ Mn)
TABLE 28 Global Precision Medicine Market, by Infectious Diseases, By Region, 2024-2032 (US$ Mn)
TABLE 29 Global Precision Medicine Market, by Hospitals and Clinics, By Region, 2019-2032 (US$ Mn)
TABLE 30 Global Precision Medicine Market, by Hospitals and Clinics, By Region, 2024-2032 (US$ Mn)
TABLE 31 Global Precision Medicine Market, by Pharmacogenomics, By Region, 2019-2032 (US$ Mn)
TABLE 32 Global Precision Medicine Market, by Pharmacogenomics, By Region, 2024-2032 (US$ Mn)
TABLE 33 Global Precision Medicine Market, by Epigenomics, By Region, 2019-2032 (US$ Mn)
TABLE 34 Global Precision Medicine Market, by Epigenomics, By Region, 2024-2032 (US$ Mn)
TABLE 35 Global Precision Medicine Market, by GENOMIC DATA, By Region, 2019-2032 (US$ Mn)
TABLE 36 Global Precision Medicine Market, by GENOMIC DATA, By Region, 2024-2032 (US$ Mn)
TABLE 37 Global Precision Medicine Market, by CLINICAL DATA, By Region, 2019-2032 (US$ Mn)
TABLE 38 Global Precision Medicine Market, by CLINICAL DATA, By Region, 2024-2032 (US$ Mn)
TABLE 39 Global Precision Medicine Market, by Patient-Centric Precision Medicine, By Region, 2019-2032 (US$ Mn)
TABLE 40 Global Precision Medicine Market, by Patient-Centric Precision Medicine, By Region, 2024-2032 (US$ Mn)
TABLE 41 Global Precision Medicine Market, by Physician-Driven Precision Medicine, By Region, 2019-2032 (US$ Mn)
TABLE 42 Global Precision Medicine Market, by Physician-Driven Precision Medicine, By Region, 2024-2032 (US$ Mn)
TABLE 43 Global Precision Medicine Market, by Diagnostics, 2019-2032 (US$ Mn)
TABLE 44 Global Precision Medicine Market, by Diagnostics, 2024-2032 (US$ Mn)
TABLE 45 Global Precision Medicine Market, By Therapeutics, 2019-2032 (US$ Mn)
TABLE 46 Global Precision Medicine Market, By Therapeutics, 2024-2032 (US$ Mn)
TABLE 47 Global Precision Medicine Market, by Technology, 2019-2032 (US$ Mn)
TABLE 48 Global Precision Medicine Market, by Technology, 2024-2032 (US$ Mn)
TABLE 49 Global Precision Medicine Market, by Application, By Region, 2019-2032 (US$ Mn)
TABLE 50 Global Precision Medicine Market, by Application, By Region, 2024-2032 (US$ Mn)
TABLE 51 Global Precision Medicine Market, By End-User, 2019-2032 (US$ Mn)
TABLE 52 Global Precision Medicine Market, By End-User, 2024-2032 (US$ Mn)
TABLE 53 Global Precision Medicine Market, by Mode of Action, 2019-2032 (US$ Mn)
TABLE 54 Global Precision Medicine Market, by Mode of Action, 2024-2032 (US$ Mn)
TABLE 55 Global Precision Medicine Market, by Data Source, 2019-2032 (US$ Mn)
TABLE 56 Global Precision Medicine Market, by Data Source, 2024-2032 (US$ Mn)
TABLE 57 Global Precision Medicine Market, by Patient Involvement, 2019-2032 (US$ Mn)
TABLE 58 Global Precision Medicine Market, by Patient Involvement, 2024-2032 (US$ Mn)
TABLE 59 Global Precision Medicine Market, by Region, 2019-2032 (US$ Mn)
TABLE 60 Global Precision Medicine Market, by Region, 2024-2032 (US$ Mn)
TABLE 61 North America Precision Medicine Market, by Diagnostics, 2019-2032 (US$ Mn)
TABLE 62 North America Precision Medicine Market, by Diagnostics, 2024-2032 (US$ Mn)
TABLE 63 North America Precision Medicine Market, By Therapeutics, 2019-2032 (US$ Mn)
TABLE 64 North America Precision Medicine Market, By Therapeutics, 2024-2032 (US$ Mn)
TABLE 65 North America Precision Medicine Market, by Technology, 2019-2032 (US$ Mn)
TABLE 66 North America Precision Medicine Market, by Technology, 2024-2032 (US$ Mn)
TABLE 67 North America Precision Medicine Market, by Application, By Region, 2019-2032 (US$ Mn)
TABLE 68 North America Precision Medicine Market, by Application, By Region, 2024-2032 (US$ Mn)
TABLE 69 North America Precision Medicine Market, By End-User, 2019-2032 (US$ Mn)
TABLE 70 North America Precision Medicine Market, By End-User, 2024-2032 (US$ Mn)
TABLE 71 North America Precision Medicine Market, by Mode of Action, 2019-2032 (US$ Mn)
TABLE 72 North America Precision Medicine Market, by Mode of Action, 2024-2032 (US$ Mn)
TABLE 73 North America Precision Medicine Market, by Data Source, 2019-2032 (US$ Mn)
TABLE 74 North America Precision Medicine Market, by Data Source, 2024-2032 (US$ Mn)
TABLE 75 North America Precision Medicine Market, by Patient Involvement, 2019-2032 (US$ Mn)
TABLE 76 North America Precision Medicine Market, by Patient Involvement, 2024-2032 (US$ Mn)
TABLE 77 North America Precision Medicine Market, by Country, 2019-2032 (US$ Mn)
TABLE 78 North America Precision Medicine Market, by Country, 2024-2032 (US$ Mn)
TABLE 79 United States Precision Medicine Market, by Diagnostics, 2019-2032 (US$ Mn)
TABLE 80 United States Precision Medicine Market, by Diagnostics, 2024-2032 (US$ Mn)
TABLE 81 United States Precision Medicine Market, By Therapeutics, 2019-2032 (US$ Mn)
TABLE 82 United States Precision Medicine Market, By Therapeutics, 2024-2032 (US$ Mn)
TABLE 83 United States Precision Medicine Market, by Technology, 2019-2032 (US$ Mn)
TABLE 84 United States Precision Medicine Market, by Technology, 2024-2032 (US$ Mn)
TABLE 85 United States Precision Medicine Market, by Application, By Region, 2019-2032 (US$ Mn)
TABLE 86 United States Precision Medicine Market, by Application, By Region, 2024-2032 (US$ Mn)
TABLE 87 United States Precision Medicine Market, By End-User, 2019-2032 (US$ Mn)
TABLE 88 United States Precision Medicine Market, By End-User, 2024-2032 (US$ Mn)
TABLE 89 United States Precision Medicine Market, by Mode of Action, 2019-2032 (US$ Mn)
TABLE 90 United States Precision Medicine Market, by Mode of Action, 2024-2032 (US$ Mn)
TABLE 91 United States Precision Medicine Market, by Data Source, 2019-2032 (US$ Mn)
TABLE 92 United States Precision Medicine Market, by Data Source, 2024-2032 (US$ Mn)
TABLE 93 United States Precision Medicine Market, by Patient Involvement, 2019-2032 (US$ Mn)
TABLE 94 United States Precision Medicine Market, by Patient Involvement, 2024-2032 (US$ Mn)
TABLE 95 Canada Precision Medicine Market, by Diagnostics, 2019-2032 (US$ Mn)
TABLE 96 Canada Precision Medicine Market, by Diagnostics, 2024-2032 (US$ Mn)
TABLE 97 Canada Precision Medicine Market, By Therapeutics, 2019-2032 (US$ Mn)
TABLE 98 Canada Precision Medicine Market, By Therapeutics, 2024-2032 (US$ Mn)
TABLE 99 Canada Precision Medicine Market, by Technology, 2019-2032 (US$ Mn)
TABLE 100 Canada Precision Medicine Market, by Technology, 2024-2032 (US$ Mn)
TABLE 101 Canada Precision Medicine Market, by Application, By Region, 2019-2032 (US$ Mn)
TABLE 102 Canada Precision Medicine Market, by Application, By Region, 2024-2032 (US$ Mn)
TABLE 103 Canada Precision Medicine Market, By End-User, 2019-2032 (US$ Mn)
TABLE 104 Canada Precision Medicine Market, By End-User, 2024-2032 (US$ Mn)
TABLE 105 Canada Precision Medicine Market, by Mode of Action, 2019-2032 (US$ Mn)
TABLE 106 Canada Precision Medicine Market, by Mode of Action, 2024-2032 (US$ Mn)
TABLE 107 Canada Precision Medicine Market, by Data Source, 2019-2032 (US$ Mn)
TABLE 108 Canada Precision Medicine Market, by Data Source, 2024-2032 (US$ Mn)
TABLE 109 Canada Precision Medicine Market, by Patient Involvement, 2019-2032 (US$ Mn)
TABLE 110 Canada Precision Medicine Market, by Patient Involvement, 2024-2032 (US$ Mn)
TABLE 111 Mexico Precision Medicine Market, by Diagnostics, 2019-2032 (US$ Mn)
TABLE 112 Mexico Precision Medicine Market, by Diagnostics, 2024-2032 (US$ Mn)
TABLE 113 Mexico Precision Medicine Market, By Therapeutics, 2019-2032 (US$ Mn)
TABLE 114 Mexico Precision Medicine Market, By Therapeutics, 2024-2032 (US$ Mn)
TABLE 115 Mexico Precision Medicine Market, by Technology, 2019-2032 (US$ Mn)
TABLE 116 Mexico Precision Medicine Market, by Technology, 2024-2032 (US$ Mn)
TABLE 117 Mexico Precision Medicine Market, by Application, By Region, 2019-2032 (US$ Mn)
TABLE 118 Mexico Precision Medicine Market, by Application, By Region, 2024-2032 (US$ Mn)
TABLE 119 Mexico Precision Medicine Market, By End-User, 2019-2032 (US$ Mn)
TABLE 120 Mexico Precision Medicine Market, By End-User, 2024-2032 (US$ Mn)
TABLE 121 Mexico Precision Medicine Market, by Mode of Action, 2019-2032 (US$ Mn)
TABLE 122 Mexico Precision Medicine Market, by Mode of Action, 2024-2032 (US$ Mn)
TABLE 123 Mexico Precision Medicine Market, by Data Source, 2019-2032 (US$ Mn)
TABLE 124 Mexico Precision Medicine Market, by Data Source, 2024-2032 (US$ Mn)
TABLE 125 Mexico Precision Medicine Market, by Patient Involvement, 2019-2032 (US$ Mn)
TABLE 126 Mexico Precision Medicine Market, by Patient Involvement, 2024-2032 (US$ Mn)
TABLE 127 Europe Precision Medicine Market, by Diagnostics, 2019-2032 (US$ Mn)
TABLE 128 Europe Precision Medicine Market, by Diagnostics, 2024-2032 (US$ Mn)
TABLE 129 Europe Precision Medicine Market, By Therapeutics, 2019-2032 (US$ Mn)
TABLE 130 Europe Precision Medicine Market, By Therapeutics, 2024-2032 (US$ Mn)
TABLE 131 Europe Precision Medicine Market, by Technology, 2019-2032 (US$ Mn)
TABLE 132 Europe Precision Medicine Market, by Technology, 2024-2032 (US$ Mn)
TABLE 133 Europe Precision Medicine Market, by Application, By Region, 2019-2032 (US$ Mn)
TABLE 134 Europe Precision Medicine Market, by Application, By Region, 2024-2032 (US$ Mn)
TABLE 135 Europe Precision Medicine Market, By End-User, 2019-2032 (US$ Mn)
TABLE 136 Europe Precision Medicine Market, By End-User, 2024-2032 (US$ Mn)
TABLE 137 Europe Precision Medicine Market, by Mode of Action, 2019-2032 (US$ Mn)
TABLE 138 Europe Precision Medicine Market, by Mode of Action, 2024-2032 (US$ Mn)
TABLE 139 Europe Precision Medicine Market, by Data Source, 2019-2032 (US$ Mn)
TABLE 140 Europe Precision Medicine Market, by Data Source, 2024-2032 (US$ Mn)
TABLE 141 Europe Precision Medicine Market, by Patient Involvement, 2019-2032 (US$ Mn)
TABLE 142 Europe Precision Medicine Market, by Patient Involvement, 2024-2032 (US$ Mn)
TABLE 143 Europe Precision Medicine Market, by Country, 2019-2032 (US$ Mn)
TABLE 144 Europe Precision Medicine Market, by Country, 2024-2032 (US$ Mn)
TABLE 145 Germany Precision Medicine Market, by Diagnostics, 2019-2032 (US$ Mn)
TABLE 146 Germany Precision Medicine Market, by Diagnostics, 2024-2032 (US$ Mn)
TABLE 147 Germany Precision Medicine Market, By Therapeutics, 2019-2032 (US$ Mn)
TABLE 148 Germany Precision Medicine Market, By Therapeutics, 2024-2032 (US$ Mn)
TABLE 149 Germany Precision Medicine Market, by Technology, 2019-2032 (US$ Mn)
TABLE 150 Germany Precision Medicine Market, by Technology, 2024-2032 (US$ Mn)
TABLE 151 Germany Precision Medicine Market, by Application, By Region, 2019-2032 (US$ Mn)
TABLE 152 Germany Precision Medicine Market, by Application, By Region, 2024-2032 (US$ Mn)
TABLE 153 Germany Precision Medicine Market, By End-User, 2019-2032 (US$ Mn)
TABLE 154 Germany Precision Medicine Market, By End-User, 2024-2032 (US$ Mn)
TABLE 155 Germany Precision Medicine Market, by Mode of Action, 2019-2032 (US$ Mn)
TABLE 156 Germany Precision Medicine Market, by Mode of Action, 2024-2032 (US$ Mn)
TABLE 157 Germany Precision Medicine Market, by Data Source, 2019-2032 (US$ Mn)
TABLE 158 Germany Precision Medicine Market, by Data Source, 2024-2032 (US$ Mn)
TABLE 159 Germany Precision Medicine Market, by Patient Involvement, 2019-2032 (US$ Mn)
TABLE 160 Germany Precision Medicine Market, by Patient Involvement, 2024-2032 (US$ Mn)
TABLE 161 France Precision Medicine Market, by Diagnostics, 2019-2032 (US$ Mn)
TABLE 162 France Precision Medicine Market, by Diagnostics, 2024-2032 (US$ Mn)
TABLE 163 France Precision Medicine Market, By Therapeutics, 2019-2032 (US$ Mn)
TABLE 164 France Precision Medicine Market, By Therapeutics, 2024-2032 (US$ Mn)
TABLE 165 France Precision Medicine Market, by Technology, 2019-2032 (US$ Mn)
TABLE 166 France Precision Medicine Market, by Technology, 2024-2032 (US$ Mn)
TABLE 167 France Precision Medicine Market, by Application, By Region, 2019-2032 (US$ Mn)
TABLE 168 France Precision Medicine Market, by Application, By Region, 2024-2032 (US$ Mn)
TABLE 169 France Precision Medicine Market, By End-User, 2019-2032 (US$ Mn)
TABLE 170 France Precision Medicine Market, By End-User, 2024-2032 (US$ Mn)
TABLE 171 France Precision Medicine Market, by Mode of Action, 2019-2032 (US$ Mn)
TABLE 172 France Precision Medicine Market, by Mode of Action, 2024-2032 (US$ Mn)
TABLE 173 France Precision Medicine Market, by Data Source, 2019-2032 (US$ Mn)
TABLE 174 France Precision Medicine Market, by Data Source, 2024-2032 (US$ Mn)
TABLE 175 France Precision Medicine Market, by Patient Involvement, 2019-2032 (US$ Mn)
TABLE 176 France Precision Medicine Market, by Patient Involvement, 2024-2032 (US$ Mn)
TABLE 177 United Kingdom Precision Medicine Market, by Diagnostics, 2019-2032 (US$ Mn)
TABLE 178 United Kingdom Precision Medicine Market, by Diagnostics, 2024-2032 (US$ Mn)
TABLE 179 United Kingdom Precision Medicine Market, By Therapeutics, 2019-2032 (US$ Mn)
TABLE 180 United Kingdom Precision Medicine Market, By Therapeutics, 2024-2032 (US$ Mn)
TABLE 181 United Kingdom Precision Medicine Market, by Technology, 2019-2032 (US$ Mn)
TABLE 182 United Kingdom Precision Medicine Market, by Technology, 2024-2032 (US$ Mn)
TABLE 183 United Kingdom Precision Medicine Market, by Application, By Region, 2019-2032 (US$ Mn)
TABLE 184 United Kingdom Precision Medicine Market, by Application, By Region, 2024-2032 (US$ Mn)
TABLE 185 United Kingdom Precision Medicine Market, By End-User, 2019-2032 (US$ Mn)
TABLE 186 United Kingdom Precision Medicine Market, By End-User, 2024-2032 (US$ Mn)
TABLE 187 United Kingdom Precision Medicine Market, by Mode of Action, 2019-2032 (US$ Mn)
TABLE 188 United Kingdom Precision Medicine Market, by Mode of Action, 2024-2032 (US$ Mn)
TABLE 189 United Kingdom Precision Medicine Market, by Data Source, 2019-2032 (US$ Mn)
TABLE 190 United Kingdom Precision Medicine Market, by Data Source, 2024-2032 (US$ Mn)
TABLE 191 United Kingdom Precision Medicine Market, by Patient Involvement, 2019-2032 (US$ Mn)
TABLE 192 United Kingdom Precision Medicine Market, by Patient Involvement, 2024-2032 (US$ Mn)
TABLE 193 Italy Precision Medicine Market, by Diagnostics, 2019-2032 (US$ Mn)
TABLE 194 Italy Precision Medicine Market, by Diagnostics, 2024-2032 (US$ Mn)
TABLE 195 Italy Precision Medicine Market, By Therapeutics, 2019-2032 (US$ Mn)
TABLE 196 Italy Precision Medicine Market, By Therapeutics, 2024-2032 (US$ Mn)
TABLE 197 Italy Precision Medicine Market, by Technology, 2019-2032 (US$ Mn)
TABLE 198 Italy Precision Medicine Market, by Technology, 2024-2032 (US$ Mn)
TABLE 199 Italy Precision Medicine Market, by Application, By Region, 2019-2032 (US$ Mn)
TABLE 200 Italy Precision Medicine Market, by Application, By Region, 2024-2032 (US$ Mn)
TABLE 201 Italy Precision Medicine Market, By End-User, 2019-2032 (US$ Mn)
TABLE 202 Italy Precision Medicine Market, By End-User, 2024-2032 (US$ Mn)
TABLE 203 Italy Precision Medicine Market, by Mode of Action, 2019-2032 (US$ Mn)
TABLE 204 Italy Precision Medicine Market, by Mode of Action, 2024-2032 (US$ Mn)
TABLE 205 Italy Precision Medicine Market, by Data Source, 2019-2032 (US$ Mn)
TABLE 206 Italy Precision Medicine Market, by Data Source, 2024-2032 (US$ Mn)
TABLE 207 Italy Precision Medicine Market, by Patient Involvement, 2019-2032 (US$ Mn)
TABLE 208 Italy Precision Medicine Market, by Patient Involvement, 2024-2032 (US$ Mn)
TABLE 209 Spain Precision Medicine Market, by Diagnostics, 2019-2032 (US$ Mn)
TABLE 210 Spain Precision Medicine Market, by Diagnostics, 2024-2032 (US$ Mn)
TABLE 211 Spain Precision Medicine Market, By Therapeutics, 2019-2032 (US$ Mn)
TABLE 212 Spain Precision Medicine Market, By Therapeutics, 2024-2032 (US$ Mn)
TABLE 213 Spain Precision Medicine Market, by Technology, 2019-2032 (US$ Mn)
TABLE 214 Spain Precision Medicine Market, by Technology, 2024-2032 (US$ Mn)
TABLE 215 Spain Precision Medicine Market, by Application, By Region, 2019-2032 (US$ Mn)
TABLE 216 Spain Precision Medicine Market, by Application, By Region, 2024-2032 (US$ Mn)
TABLE 217 Spain Precision Medicine Market, By End-User, 2019-2032 (US$ Mn)
TABLE 218 Spain Precision Medicine Market, By End-User, 2024-2032 (US$ Mn)
TABLE 219 Spain Precision Medicine Market, by Mode of Action, 2019-2032 (US$ Mn)
TABLE 220 Spain Precision Medicine Market, by Mode of Action, 2024-2032 (US$ Mn)
TABLE 221 Spain Precision Medicine Market, by Data Source, 2019-2032 (US$ Mn)
TABLE 222 Spain Precision Medicine Market, by Data Source, 2024-2032 (US$ Mn)
TABLE 223 Spain Precision Medicine Market, by Patient Involvement, 2019-2032 (US$ Mn)
TABLE 224 Spain Precision Medicine Market, by Patient Involvement, 2024-2032 (US$ Mn)
TABLE 225 Benelux Precision Medicine Market, by Diagnostics, 2019-2032 (US$ Mn)
TABLE 226 Benelux Precision Medicine Market, by Diagnostics, 2024-2032 (US$ Mn)
TABLE 227 Benelux Precision Medicine Market, By Therapeutics, 2019-2032 (US$ Mn)
TABLE 228 Benelux Precision Medicine Market, By Therapeutics, 2024-2032 (US$ Mn)
TABLE 229 Benelux Precision Medicine Market, by Technology, 2019-2032 (US$ Mn)
TABLE 230 Benelux Precision Medicine Market, by Technology, 2024-2032 (US$ Mn)
TABLE 231 Benelux Precision Medicine Market, by Application, By Region, 2019-2032 (US$ Mn)
TABLE 232 Benelux Precision Medicine Market, by Application, By Region, 2024-2032 (US$ Mn)
TABLE 233 Benelux Precision Medicine Market, By End-User, 2019-2032 (US$ Mn)
TABLE 234 Benelux Precision Medicine Market, By End-User, 2024-2032 (US$ Mn)
TABLE 235 Benelux Precision Medicine Market, by Mode of Action, 2019-2032 (US$ Mn)
TABLE 236 Benelux Precision Medicine Market, by Mode of Action, 2024-2032 (US$ Mn)
TABLE 237 Benelux Precision Medicine Market, by Data Source, 2019-2032 (US$ Mn)
TABLE 238 Benelux Precision Medicine Market, by Data Source, 2024-2032 (US$ Mn)
TABLE 239 Benelux Precision Medicine Market, by Patient Involvement, 2019-2032 (US$ Mn)
TABLE 240 Benelux Precision Medicine Market, by Patient Involvement, 2024-2032 (US$ Mn)
TABLE 241 Russia Precision Medicine Market, by Diagnostics, 2019-2032 (US$ Mn)
TABLE 242 Russia Precision Medicine Market, by Diagnostics, 2024-2032 (US$ Mn)
TABLE 243 Russia Precision Medicine Market, By Therapeutics, 2019-2032 (US$ Mn)
TABLE 244 Russia Precision Medicine Market, By Therapeutics, 2024-2032 (US$ Mn)
TABLE 245 Russia Precision Medicine Market, by Technology, 2019-2032 (US$ Mn)
TABLE 246 Russia Precision Medicine Market, by Technology, 2024-2032 (US$ Mn)
TABLE 247 Russia Precision Medicine Market, by Application, By Region, 2019-2032 (US$ Mn)
TABLE 248 Russia Precision Medicine Market, by Application, By Region, 2024-2032 (US$ Mn)
TABLE 249 Russia Precision Medicine Market, By End-User, 2019-2032 (US$ Mn)
TABLE 250 Russia Precision Medicine Market, By End-User, 2024-2032 (US$ Mn)
TABLE 251 Russia Precision Medicine Market, by Mode of Action, 2019-2032 (US$ Mn)
TABLE 252 Russia Precision Medicine Market, by Mode of Action, 2024-2032 (US$ Mn)
TABLE 253 Russia Precision Medicine Market, by Data Source, 2019-2032 (US$ Mn)
TABLE 254 Russia Precision Medicine Market, by Data Source, 2024-2032 (US$ Mn)
TABLE 255 Russia Precision Medicine Market, by Patient Involvement, 2019-2032 (US$ Mn)
TABLE 256 Russia Precision Medicine Market, by Patient Involvement, 2024-2032 (US$ Mn)
TABLE 257 Rest of Europe Precision Medicine Market, by Diagnostics, 2019-2032 (US$ Mn)
TABLE 258 Rest of Europe Precision Medicine Market, by Diagnostics, 2024-2032 (US$ Mn)
TABLE 259 Rest of Europe Precision Medicine Market, By Therapeutics, 2019-2032 (US$ Mn)
TABLE 260 Rest of Europe Precision Medicine Market, By Therapeutics, 2024-2032 (US$ Mn)
TABLE 261 Rest of Europe Precision Medicine Market, by Technology, 2019-2032 (US$ Mn)
TABLE 262 Rest of Europe Precision Medicine Market, by Technology, 2024-2032 (US$ Mn)
TABLE 263 Rest of Europe Precision Medicine Market, by Application, By Region, 2019-2032 (US$ Mn)
TABLE 264 Rest of Europe Precision Medicine Market, by Application, By Region, 2024-2032 (US$ Mn)
TABLE 265 Rest of Europe Precision Medicine Market, By End-User, 2019-2032 (US$ Mn)
TABLE 266 Rest of Europe Precision Medicine Market, By End-User, 2024-2032 (US$ Mn)
TABLE 267 Rest of Europe Precision Medicine Market, by Mode of Action, 2019-2032 (US$ Mn)
TABLE 268 Rest of Europe Precision Medicine Market, by Mode of Action, 2024-2032 (US$ Mn)
TABLE 269 Rest of Europe Precision Medicine Market, by Data Source, 2019-2032 (US$ Mn)
TABLE 270 Rest of Europe Precision Medicine Market, by Data Source, 2024-2032 (US$ Mn)
TABLE 271 Rest of Europe Precision Medicine Market, by Patient Involvement, 2019-2032 (US$ Mn)
TABLE 272 Rest of Europe Precision Medicine Market, by Patient Involvement, 2024-2032 (US$ Mn)
TABLE 273 Asia Pacific Precision Medicine Market, by Diagnostics, 2019-2032 (US$ Mn)
TABLE 274 Asia Pacific Precision Medicine Market, by Diagnostics, 2024-2032 (US$ Mn)
TABLE 275 Asia Pacific Precision Medicine Market, By Therapeutics, 2019-2032 (US$ Mn)
TABLE 276 Asia Pacific Precision Medicine Market, By Therapeutics, 2024-2032 (US$ Mn)
TABLE 277 Asia Pacific Precision Medicine Market, by Technology, 2019-2032 (US$ Mn)
TABLE 278 Asia Pacific Precision Medicine Market, by Technology, 2024-2032 (US$ Mn)
TABLE 279 Asia Pacific Precision Medicine Market, by Application, By Region, 2019-2032 (US$ Mn)
TABLE 280 Asia Pacific Precision Medicine Market, by Application, By Region, 2024-2032 (US$ Mn)
TABLE 281 Asia Pacific Precision Medicine Market, By End-User, 2019-2032 (US$ Mn)
TABLE 282 Asia Pacific Precision Medicine Market, By End-User, 2024-2032 (US$ Mn)
TABLE 283 Asia Pacific Precision Medicine Market, by Mode of Action, 2019-2032 (US$ Mn)
TABLE 284 Asia Pacific Precision Medicine Market, by Mode of Action, 2024-2032 (US$ Mn)
TABLE 285 Asia Pacific Precision Medicine Market, by Data Source, 2019-2032 (US$ Mn)
TABLE 286 Asia Pacific Precision Medicine Market, by Data Source, 2024-2032 (US$ Mn)
TABLE 287 Asia Pacific Precision Medicine Market, by Patient Involvement, 2019-2032 (US$ Mn)
TABLE 288 Asia Pacific Precision Medicine Market, by Patient Involvement, 2024-2032 (US$ Mn)
TABLE 289 China Precision Medicine Market, by Diagnostics, 2019-2032 (US$ Mn)
TABLE 290 China Precision Medicine Market, by Diagnostics, 2024-2032 (US$ Mn)
TABLE 291 China Precision Medicine Market, By Therapeutics, 2019-2032 (US$ Mn)
TABLE 292 China Precision Medicine Market, By Therapeutics, 2024-2032 (US$ Mn)
TABLE 293 China Precision Medicine Market, by Technology, 2019-2032 (US$ Mn)
TABLE 294 China Precision Medicine Market, by Technology, 2024-2032 (US$ Mn)
TABLE 295 China Precision Medicine Market, by Application, By Region, 2019-2032 (US$ Mn)
TABLE 296 China Precision Medicine Market, by Application, By Region, 2024-2032 (US$ Mn)
TABLE 297 China Precision Medicine Market, By End-User, 2019-2032 (US$ Mn)
TABLE 298 China Precision Medicine Market, By End-User, 2024-2032 (US$ Mn)
TABLE 299 China Precision Medicine Market, by Mode of Action, 2019-2032 (US$ Mn)
TABLE 300 China Precision Medicine Market, by Mode of Action, 2024-2032 (US$ Mn)
TABLE 301 China Precision Medicine Market, by Data Source, 2019-2032 (US$ Mn)
TABLE 302 China Precision Medicine Market, by Data Source, 2024-2032 (US$ Mn)
TABLE 303 China Precision Medicine Market, by Patient Involvement, 2019-2032 (US$ Mn)
TABLE 304 China Precision Medicine Market, by Patient Involvement, 2024-2032 (US$ Mn)
TABLE 305 Japan Precision Medicine Market, by Diagnostics, 2019-2032 (US$ Mn)
TABLE 306 Japan Precision Medicine Market, by Diagnostics, 2024-2032 (US$ Mn)
TABLE 307 Japan Precision Medicine Market, By Therapeutics, 2019-2032 (US$ Mn)
TABLE 308 Japan Precision Medicine Market, By Therapeutics, 2024-2032 (US$ Mn)
TABLE 309 Japan Precision Medicine Market, by Technology, 2019-2032 (US$ Mn)
TABLE 310 Japan Precision Medicine Market, by Technology, 2024-2032 (US$ Mn)
TABLE 311 Japan Precision Medicine Market, by Application, By Region, 2019-2032 (US$ Mn)
TABLE 312 Japan Precision Medicine Market, by Application, By Region, 2024-2032 (US$ Mn)
TABLE 313 Japan Precision Medicine Market, By End-User, 2019-2032 (US$ Mn)
TABLE 314 Japan Precision Medicine Market, By End-User, 2024-2032 (US$ Mn)
TABLE 315 Japan Precision Medicine Market, by Mode of Action, 2019-2032 (US$ Mn)
TABLE 316 Japan Precision Medicine Market, by Mode of Action, 2024-2032 (US$ Mn)
TABLE 317 Japan Precision Medicine Market, by Data Source, 2019-2032 (US$ Mn)
TABLE 318 Japan Precision Medicine Market, by Data Source, 2024-2032 (US$ Mn)
TABLE 319 Japan Precision Medicine Market, by Patient Involvement, 2019-2032 (US$ Mn)
TABLE 320 Japan Precision Medicine Market, by Patient Involvement, 2024-2032 (US$ Mn)
TABLE 321 India Precision Medicine Market, by Diagnostics, 2019-2032 (US$ Mn)
TABLE 322 India Precision Medicine Market, by Diagnostics, 2024-2032 (US$ Mn)
TABLE 323 India Precision Medicine Market, By Therapeutics, 2019-2032 (US$ Mn)
TABLE 324 India Precision Medicine Market, By Therapeutics, 2024-2032 (US$ Mn)
TABLE 325 India Precision Medicine Market, by Technology, 2019-2032 (US$ Mn)
TABLE 326 India Precision Medicine Market, by Technology, 2024-2032 (US$ Mn)
TABLE 327 India Precision Medicine Market, by Application, By Region, 2019-2032 (US$ Mn)
TABLE 328 India Precision Medicine Market, by Application, By Region, 2024-2032 (US$ Mn)
TABLE 329 India Precision Medicine Market, By End-User, 2019-2032 (US$ Mn)
TABLE 330 India Precision Medicine Market, By End-User, 2024-2032 (US$ Mn)
TABLE 331 India Precision Medicine Market, by Mode of Action, 2019-2032 (US$ Mn)
TABLE 332 India Precision Medicine Market, by Mode of Action, 2024-2032 (US$ Mn)
TABLE 333 India Precision Medicine Market, by Data Source, 2019-2032 (US$ Mn)
TABLE 334 India Precision Medicine Market, by Data Source, 2024-2032 (US$ Mn)
TABLE 335 India Precision Medicine Market, by Patient Involvement, 2019-2032 (US$ Mn)
TABLE 336 India Precision Medicine Market, by Patient Involvement, 2024-2032 (US$ Mn)
TABLE 337 South Korea Precision Medicine Market, by Diagnostics, 2019-2032 (US$ Mn)
TABLE 338 South Korea Precision Medicine Market, by Diagnostics, 2024-2032 (US$ Mn)
TABLE 339 South Korea Precision Medicine Market, By Therapeutics, 2019-2032 (US$ Mn)
TABLE 340 South Korea Precision Medicine Market, By Therapeutics, 2024-2032 (US$ Mn)
TABLE 341 South Korea Precision Medicine Market, by Technology, 2019-2032 (US$ Mn)
TABLE 342 South Korea Precision Medicine Market, by Technology, 2024-2032 (US$ Mn)
TABLE 343 South Korea Precision Medicine Market, by Application, By Region, 2019-2032 (US$ Mn)
TABLE 344 South Korea Precision Medicine Market, by Application, By Region, 2024-2032 (US$ Mn)
TABLE 345 South Korea Precision Medicine Market, By End-User, 2019-2032 (US$ Mn)
TABLE 346 South Korea Precision Medicine Market, By End-User, 2024-2032 (US$ Mn)
TABLE 347 South Korea Precision Medicine Market, by Mode of Action, 2019-2032 (US$ Mn)
TABLE 348 South Korea Precision Medicine Market, by Mode of Action, 2024-2032 (US$ Mn)
TABLE 349 South Korea Precision Medicine Market, by Data Source, 2019-2032 (US$ Mn)
TABLE 350 South Korea Precision Medicine Market, by Data Source, 2024-2032 (US$ Mn)
TABLE 351 South Korea Precision Medicine Market, by Patient Involvement, 2019-2032 (US$ Mn)
TABLE 352 South Korea Precision Medicine Market, by Patient Involvement, 2024-2032 (US$ Mn)
TABLE 353 South-East Asia Precision Medicine Market, by Diagnostics, 2019-2032 (US$ Mn)
TABLE 354 South-East Asia Precision Medicine Market, by Diagnostics, 2024-2032 (US$ Mn)
TABLE 355 South-East Asia Precision Medicine Market, By Therapeutics, 2019-2032 (US$ Mn)
TABLE 356 South-East Asia Precision Medicine Market, By Therapeutics, 2024-2032 (US$ Mn)
TABLE 357 South-East Asia Precision Medicine Market, by Technology, 2019-2032 (US$ Mn)
TABLE 358 South-East Asia Precision Medicine Market, by Technology, 2024-2032 (US$ Mn)
TABLE 359 South-East Asia Precision Medicine Market, by Application, By Region, 2019-2032 (US$ Mn)
TABLE 360 South-East Asia Precision Medicine Market, by Application, By Region, 2024-2032 (US$ Mn)
TABLE 361 South-East Asia Precision Medicine Market, By End-User, 2019-2032 (US$ Mn)
TABLE 362 South-East Asia Precision Medicine Market, By End-User, 2024-2032 (US$ Mn)
TABLE 363 South-East Asia Precision Medicine Market, by Mode of Action, 2019-2032 (US$ Mn)
TABLE 364 South-East Asia Precision Medicine Market, by Mode of Action, 2024-2032 (US$ Mn)
TABLE 365 South-East Asia Precision Medicine Market, by Data Source, 2019-2032 (US$ Mn)
TABLE 366 South-East Asia Precision Medicine Market, by Data Source, 2024-2032 (US$ Mn)
TABLE 367 South-East Asia Precision Medicine Market, by Patient Involvement, 2019-2032 (US$ Mn)
TABLE 368 South-East Asia Precision Medicine Market, by Patient Involvement, 2024-2032 (US$ Mn)
TABLE 369 Rest of Asia Pacific Precision Medicine Market, by Diagnostics, 2019-2032 (US$ Mn)
TABLE 370 Rest of Asia Pacific Precision Medicine Market, by Diagnostics, 2024-2032 (US$ Mn)
TABLE 371 Rest of Asia Pacific Precision Medicine Market, By Therapeutics, 2019-2032 (US$ Mn)
TABLE 372 Rest of Asia Pacific Precision Medicine Market, By Therapeutics, 2024-2032 (US$ Mn)
TABLE 373 Rest of Asia Pacific Precision Medicine Market, by Technology, 2019-2032 (US$ Mn)
TABLE 374 Rest of Asia Pacific Precision Medicine Market, by Technology, 2024-2032 (US$ Mn)
TABLE 375 Rest of Asia Pacific Precision Medicine Market, by Application, By Region, 2019-2032 (US$ Mn)
TABLE 376 Rest of Asia Pacific Precision Medicine Market, by Application, By Region, 2024-2032 (US$ Mn)
TABLE 377 Rest of Asia Pacific Precision Medicine Market, By End-User, 2019-2032 (US$ Mn)
TABLE 378 Rest of Asia Pacific Precision Medicine Market, By End-User, 2024-2032 (US$ Mn)
TABLE 379 Rest of Asia Pacific Precision Medicine Market, by Mode of Action, 2019-2032 (US$ Mn)
TABLE 380 Rest of Asia Pacific Precision Medicine Market, by Mode of Action, 2024-2032 (US$ Mn)
TABLE 381 Rest of Asia Pacific Precision Medicine Market, by Data Source, 2019-2032 (US$ Mn)
TABLE 382 Rest of Asia Pacific Precision Medicine Market, by Data Source, 2024-2032 (US$ Mn)
TABLE 383 Rest of Asia Pacific Precision Medicine Market, by Patient Involvement, 2019-2032 (US$ Mn)
TABLE 384 Rest of Asia Pacific Precision Medicine Market, by Patient Involvement, 2024-2032 (US$ Mn)
TABLE 385 Latin America Precision Medicine Market, by Diagnostics, 2019-2032 (US$ Mn)
TABLE 386 Latin America Precision Medicine Market, by Diagnostics, 2024-2032 (US$ Mn)
TABLE 387 Latin America Precision Medicine Market, By Therapeutics, 2019-2032 (US$ Mn)
TABLE 388 Latin America Precision Medicine Market, By Therapeutics, 2024-2032 (US$ Mn)
TABLE 389 Latin America Precision Medicine Market, by Technology, 2019-2032 (US$ Mn)
TABLE 390 Latin America Precision Medicine Market, by Technology, 2024-2032 (US$ Mn)
TABLE 391 Latin America Precision Medicine Market, by Application, By Region, 2019-2032 (US$ Mn)
TABLE 392 Latin America Precision Medicine Market, by Application, By Region, 2024-2032 (US$ Mn)
TABLE 393 Latin America Precision Medicine Market, By End-User, 2019-2032 (US$ Mn)
TABLE 394 Latin America Precision Medicine Market, By End-User, 2024-2032 (US$ Mn)
TABLE 395 Latin America Precision Medicine Market, by Mode of Action, 2019-2032 (US$ Mn)
TABLE 396 Latin America Precision Medicine Market, by Mode of Action, 2024-2032 (US$ Mn)
TABLE 397 Latin America Precision Medicine Market, by Data Source, 2019-2032 (US$ Mn)
TABLE 398 Latin America Precision Medicine Market, by Data Source, 2024-2032 (US$ Mn)
TABLE 399 Latin America Precision Medicine Market, by Patient Involvement, 2019-2032 (US$ Mn)
TABLE 400 Latin America Precision Medicine Market, by Patient Involvement, 2024-2032 (US$ Mn)
TABLE 401 Brazil Precision Medicine Market, by Diagnostics, 2019-2032 (US$ Mn)
TABLE 402 Brazil Precision Medicine Market, by Diagnostics, 2024-2032 (US$ Mn)
TABLE 403 Brazil Precision Medicine Market, By Therapeutics, 2019-2032 (US$ Mn)
TABLE 404 Brazil Precision Medicine Market, By Therapeutics, 2024-2032 (US$ Mn)
TABLE 405 Brazil Precision Medicine Market, by Technology, 2019-2032 (US$ Mn)
TABLE 406 Brazil Precision Medicine Market, by Technology, 2024-2032 (US$ Mn)
TABLE 407 Brazil Precision Medicine Market, by Application, By Region, 2019-2032 (US$ Mn)
TABLE 408 Brazil Precision Medicine Market, by Application, By Region, 2024-2032 (US$ Mn)
TABLE 409 Brazil Precision Medicine Market, By End-User, 2019-2032 (US$ Mn)
TABLE 410 Brazil Precision Medicine Market, By End-User, 2024-2032 (US$ Mn)
TABLE 411 Brazil Precision Medicine Market, by Mode of Action, 2019-2032 (US$ Mn)
TABLE 412 Brazil Precision Medicine Market, by Mode of Action, 2024-2032 (US$ Mn)
TABLE 413 Brazil Precision Medicine Market, by Data Source, 2019-2032 (US$ Mn)
TABLE 414 Brazil Precision Medicine Market, by Data Source, 2024-2032 (US$ Mn)
TABLE 415 Brazil Precision Medicine Market, by Patient Involvement, 2019-2032 (US$ Mn)
TABLE 416 Brazil Precision Medicine Market, by Patient Involvement, 2024-2032 (US$ Mn)
TABLE 417 Argentina Precision Medicine Market, by Diagnostics, 2019-2032 (US$ Mn)
TABLE 418 Argentina Precision Medicine Market, by Diagnostics, 2024-2032 (US$ Mn)
TABLE 419 Argentina Precision Medicine Market, By Therapeutics, 2019-2032 (US$ Mn)
TABLE 420 Argentina Precision Medicine Market, By Therapeutics, 2024-2032 (US$ Mn)
TABLE 421 Argentina Precision Medicine Market, by Technology, 2019-2032 (US$ Mn)
TABLE 422 Argentina Precision Medicine Market, by Technology, 2024-2032 (US$ Mn)
TABLE 423 Argentina Precision Medicine Market, by Application, By Region, 2019-2032 (US$ Mn)
TABLE 424 Argentina Precision Medicine Market, by Application, By Region, 2024-2032 (US$ Mn)
TABLE 425 Argentina Precision Medicine Market, By End-User, 2019-2032 (US$ Mn)
TABLE 426 Argentina Precision Medicine Market, By End-User, 2024-2032 (US$ Mn)
TABLE 427 Argentina Precision Medicine Market, by Mode of Action, 2019-2032 (US$ Mn)
TABLE 428 Argentina Precision Medicine Market, by Mode of Action, 2024-2032 (US$ Mn)
TABLE 429 Argentina Precision Medicine Market, by Data Source, 2019-2032 (US$ Mn)
TABLE 430 Argentina Precision Medicine Market, by Data Source, 2024-2032 (US$ Mn)
TABLE 431 Argentina Precision Medicine Market, by Patient Involvement, 2019-2032 (US$ Mn)
TABLE 432 Argentina Precision Medicine Market, by Patient Involvement, 2024-2032 (US$ Mn)
TABLE 433 Rest of Latin America Precision Medicine Market, by Diagnostics, 2019-2032 (US$ Mn)
TABLE 434 Rest of Latin America Precision Medicine Market, by Diagnostics, 2024-2032 (US$ Mn)
TABLE 435 Rest of Latin America Precision Medicine Market, By Therapeutics, 2019-2032 (US$ Mn)
TABLE 436 Rest of Latin America Precision Medicine Market, By Therapeutics, 2024-2032 (US$ Mn)
TABLE 437 Rest of Latin America Precision Medicine Market, by Technology, 2019-2032 (US$ Mn)
TABLE 438 Rest of Latin America Precision Medicine Market, by Technology, 2024-2032 (US$ Mn)
TABLE 439 Rest of Latin America Precision Medicine Market, by Application, By Region, 2019-2032 (US$ Mn)
TABLE 440 Rest of Latin America Precision Medicine Market, by Application, By Region, 2024-2032 (US$ Mn)
TABLE 441 Rest of Latin America Precision Medicine Market, By End-User, 2019-2032 (US$ Mn)
TABLE 442 Rest of Latin America Precision Medicine Market, By End-User, 2024-2032 (US$ Mn)
TABLE 443 Rest of Latin America Precision Medicine Market, by Mode of Action, 2019-2032 (US$ Mn)
TABLE 444 Rest of Latin America Precision Medicine Market, by Mode of Action, 2024-2032 (US$ Mn)
TABLE 445 Rest of Latin America Precision Medicine Market, by Data Source, 2019-2032 (US$ Mn)
TABLE 446 Rest of Latin America Precision Medicine Market, by Data Source, 2024-2032 (US$ Mn)
TABLE 447 Rest of Latin America Precision Medicine Market, by Patient Involvement, 2019-2032 (US$ Mn)
TABLE 448 Rest of Latin America Precision Medicine Market, by Patient Involvement, 2024-2032 (US$ Mn)
TABLE 449 Middle East Precision Medicine Market, by Diagnostics, 2019-2032 (US$ Mn)
TABLE 450 Middle East Precision Medicine Market, by Diagnostics, 2024-2032 (US$ Mn)
TABLE 451 Middle East Precision Medicine Market, By Therapeutics, 2019-2032 (US$ Mn)
TABLE 452 Middle East Precision Medicine Market, By Therapeutics, 2024-2032 (US$ Mn)
TABLE 453 Middle East Precision Medicine Market, by Technology, 2019-2032 (US$ Mn)
TABLE 454 Middle East Precision Medicine Market, by Technology, 2024-2032 (US$ Mn)
TABLE 455 Middle East Precision Medicine Market, by Application, By Region, 2019-2032 (US$ Mn)
TABLE 456 Middle East Precision Medicine Market, by Application, By Region, 2024-2032 (US$ Mn)
TABLE 457 Middle East Precision Medicine Market, By End-User, 2019-2032 (US$ Mn)
TABLE 458 Middle East Precision Medicine Market, By End-User, 2024-2032 (US$ Mn)
TABLE 459 Middle East Precision Medicine Market, by Mode of Action, 2019-2032 (US$ Mn)
TABLE 460 Middle East Precision Medicine Market, by Mode of Action, 2024-2032 (US$ Mn)
TABLE 461 Middle East Precision Medicine Market, by Data Source, 2019-2032 (US$ Mn)
TABLE 462 Middle East Precision Medicine Market, by Data Source, 2024-2032 (US$ Mn)
TABLE 463 Middle East Precision Medicine Market, by Patient Involvement, 2019-2032 (US$ Mn)
TABLE 464 Middle East Precision Medicine Market, by Patient Involvement, 2024-2032 (US$ Mn)
TABLE 465 UAE Precision Medicine Market, by Diagnostics, 2019-2032 (US$ Mn)
TABLE 466 UAE Precision Medicine Market, by Diagnostics, 2024-2032 (US$ Mn)
TABLE 467 UAE Precision Medicine Market, By Therapeutics, 2019-2032 (US$ Mn)
TABLE 468 UAE Precision Medicine Market, By Therapeutics, 2024-2032 (US$ Mn)
TABLE 469 UAE Precision Medicine Market, by Technology, 2019-2032 (US$ Mn)
TABLE 470 UAE Precision Medicine Market, by Technology, 2024-2032 (US$ Mn)
TABLE 471 UAE Precision Medicine Market, by Application, By Region, 2019-2032 (US$ Mn)
TABLE 472 UAE Precision Medicine Market, by Application, By Region, 2024-2032 (US$ Mn)
TABLE 473 UAE Precision Medicine Market, By End-User, 2019-2032 (US$ Mn)
TABLE 474 UAE Precision Medicine Market, By End-User, 2024-2032 (US$ Mn)
TABLE 475 UAE Precision Medicine Market, by Mode of Action, 2019-2032 (US$ Mn)
TABLE 476 UAE Precision Medicine Market, by Mode of Action, 2024-2032 (US$ Mn)
TABLE 477 UAE Precision Medicine Market, by Data Source, 2019-2032 (US$ Mn)
TABLE 478 UAE Precision Medicine Market, by Data Source, 2024-2032 (US$ Mn)
TABLE 479 UAE Precision Medicine Market, by Patient Involvement, 2019-2032 (US$ Mn)
TABLE 480 UAE Precision Medicine Market, by Patient Involvement, 2024-2032 (US$ Mn)
TABLE 481 Saudi Arabia Precision Medicine Market, by Diagnostics, 2019-2032 (US$ Mn)
TABLE 482 Saudi Arabia Precision Medicine Market, by Diagnostics, 2024-2032 (US$ Mn)
TABLE 483 Saudi Arabia Precision Medicine Market, By Therapeutics, 2019-2032 (US$ Mn)
TABLE 484 Saudi Arabia Precision Medicine Market, By Therapeutics, 2024-2032 (US$ Mn)
TABLE 485 Saudi Arabia Precision Medicine Market, by Technology, 2019-2032 (US$ Mn)
TABLE 486 Saudi Arabia Precision Medicine Market, by Technology, 2024-2032 (US$ Mn)
TABLE 487 Saudi Arabia Precision Medicine Market, by Application, By Region, 2019-2032 (US$ Mn)
TABLE 488 Saudi Arabia Precision Medicine Market, by Application, By Region, 2024-2032 (US$ Mn)
TABLE 489 Saudi Arabia Precision Medicine Market, By End-User, 2019-2032 (US$ Mn)
TABLE 490 Saudi Arabia Precision Medicine Market, By End-User, 2024-2032 (US$ Mn)
TABLE 491 Saudi Arabia Precision Medicine Market, by Mode of Action, 2019-2032 (US$ Mn)
TABLE 492 Saudi Arabia Precision Medicine Market, by Mode of Action, 2024-2032 (US$ Mn)
TABLE 493 Saudi Arabia Precision Medicine Market, by Data Source, 2019-2032 (US$ Mn)
TABLE 494 Saudi Arabia Precision Medicine Market, by Data Source, 2024-2032 (US$ Mn)
TABLE 495 Saudi Arabia Precision Medicine Market, by Patient Involvement, 2019-2032 (US$ Mn)
TABLE 496 Saudi Arabia Precision Medicine Market, by Patient Involvement, 2024-2032 (US$ Mn)
TABLE 497 Rest of Middle East Precision Medicine Market, by Diagnostics, 2019-2032 (US$ Mn)
TABLE 498 Rest of Middle East Precision Medicine Market, by Diagnostics, 2024-2032 (US$ Mn)
TABLE 499 Rest of Middle East Precision Medicine Market, By Therapeutics, 2019-2032 (US$ Mn)
TABLE 500 Rest of Middle East Precision Medicine Market, By Therapeutics, 2024-2032 (US$ Mn)
TABLE 501 Rest of Middle East Precision Medicine Market, by Technology, 2019-2032 (US$ Mn)
TABLE 502 Rest of Middle East Precision Medicine Market, by Technology, 2024-2032 (US$ Mn)
TABLE 503 Rest of Middle East Precision Medicine Market, by Application, By Region, 2019-2032 (US$ Mn)
TABLE 504 Rest of Middle East Precision Medicine Market, by Application, By Region, 2024-2032 (US$ Mn)
TABLE 505 Rest of Middle East Precision Medicine Market, By End-User, 2019-2032 (US$ Mn)
TABLE 506 Rest of Middle East Precision Medicine Market, By End-User, 2024-2032 (US$ Mn)
TABLE 507 Rest of Middle East Precision Medicine Market, by Mode of Action, 2019-2032 (US$ Mn)
TABLE 508 Rest of Middle East Precision Medicine Market, by Mode of Action, 2024-2032 (US$ Mn)
TABLE 509 Rest of Middle East Precision Medicine Market, by Data Source, 2019-2032 (US$ Mn)
TABLE 510 Rest of Middle East Precision Medicine Market, by Data Source, 2024-2032 (US$ Mn)
TABLE 511 Rest of Middle East Precision Medicine Market, by Patient Involvement, 2019-2032 (US$ Mn)
TABLE 512 Rest of Middle East Precision Medicine Market, by Patient Involvement, 2024-2032 (US$ Mn)
TABLE 513 Africa Precision Medicine Market, by Diagnostics, 2019-2032 (US$ Mn)
TABLE 514 Africa Precision Medicine Market, by Diagnostics, 2024-2032 (US$ Mn)
TABLE 515 Africa Precision Medicine Market, By Therapeutics, 2019-2032 (US$ Mn)
TABLE 516 Africa Precision Medicine Market, By Therapeutics, 2024-2032 (US$ Mn)
TABLE 517 Africa Precision Medicine Market, by Technology, 2019-2032 (US$ Mn)
TABLE 518 Africa Precision Medicine Market, by Technology, 2024-2032 (US$ Mn)
TABLE 519 Africa Precision Medicine Market, by Application, By Region, 2019-2032 (US$ Mn)
TABLE 520 Africa Precision Medicine Market, by Application, By Region, 2024-2032 (US$ Mn)
TABLE 521 Africa Precision Medicine Market, By End-User, 2019-2032 (US$ Mn)
TABLE 522 Africa Precision Medicine Market, By End-User, 2024-2032 (US$ Mn)
TABLE 523 Africa Precision Medicine Market, by Mode of Action, 2019-2032 (US$ Mn)
TABLE 524 Africa Precision Medicine Market, by Mode of Action, 2024-2032 (US$ Mn)
TABLE 525 Africa Precision Medicine Market, by Data Source, 2019-2032 (US$ Mn)
TABLE 526 Africa Precision Medicine Market, by Data Source, 2024-2032 (US$ Mn)
TABLE 527 Africa Precision Medicine Market, by Patient Involvement, 2019-2032 (US$ Mn)
TABLE 528 Africa Precision Medicine Market, by Patient Involvement, 2024-2032 (US$ Mn)
TABLE 529 South Africa Precision Medicine Market, by Diagnostics, 2019-2032 (US$ Mn)
TABLE 530 South Africa Precision Medicine Market, by Diagnostics, 2024-2032 (US$ Mn)
TABLE 531 South Africa Precision Medicine Market, By Therapeutics, 2019-2032 (US$ Mn)
TABLE 532 South Africa Precision Medicine Market, By Therapeutics, 2024-2032 (US$ Mn)
TABLE 533 South Africa Precision Medicine Market, by Technology, 2019-2032 (US$ Mn)
TABLE 534 South Africa Precision Medicine Market, by Technology, 2024-2032 (US$ Mn)
TABLE 535 South Africa Precision Medicine Market, by Application, By Region, 2019-2032 (US$ Mn)
TABLE 536 South Africa Precision Medicine Market, by Application, By Region, 2024-2032 (US$ Mn)
TABLE 537 South Africa Precision Medicine Market, By End-User, 2019-2032 (US$ Mn)
TABLE 538 South Africa Precision Medicine Market, By End-User, 2024-2032 (US$ Mn)
TABLE 539 South Africa Precision Medicine Market, by Mode of Action, 2019-2032 (US$ Mn)
TABLE 540 South Africa Precision Medicine Market, by Mode of Action, 2024-2032 (US$ Mn)
TABLE 541 South Africa Precision Medicine Market, by Data Source, 2019-2032 (US$ Mn)
TABLE 542 South Africa Precision Medicine Market, by Data Source, 2024-2032 (US$ Mn)
TABLE 543 South Africa Precision Medicine Market, by Patient Involvement, 2019-2032 (US$ Mn)
TABLE 544 South Africa Precision Medicine Market, by Patient Involvement, 2024-2032 (US$ Mn)
TABLE 545 Egypt Precision Medicine Market, by Diagnostics, 2019-2032 (US$ Mn)
TABLE 546 Egypt Precision Medicine Market, by Diagnostics, 2024-2032 (US$ Mn)
TABLE 547 Egypt Precision Medicine Market, By Therapeutics, 2019-2032 (US$ Mn)
TABLE 548 Egypt Precision Medicine Market, By Therapeutics, 2024-2032 (US$ Mn)
TABLE 549 Egypt Precision Medicine Market, by Technology, 2019-2032 (US$ Mn)
TABLE 550 Egypt Precision Medicine Market, by Technology, 2024-2032 (US$ Mn)
TABLE 551 Egypt Precision Medicine Market, by Application, By Region, 2019-2032 (US$ Mn)
TABLE 552 Egypt Precision Medicine Market, by Application, By Region, 2024-2032 (US$ Mn)
TABLE 553 Egypt Precision Medicine Market, By End-User, 2019-2032 (US$ Mn)
TABLE 554 Egypt Precision Medicine Market, By End-User, 2024-2032 (US$ Mn)
TABLE 555 Egypt Precision Medicine Market, by Mode of Action, 2019-2032 (US$ Mn)
TABLE 556 Egypt Precision Medicine Market, by Mode of Action, 2024-2032 (US$ Mn)
TABLE 557 Egypt Precision Medicine Market, by Data Source, 2019-2032 (US$ Mn)
TABLE 558 Egypt Precision Medicine Market, by Data Source, 2024-2032 (US$ Mn)
TABLE 559 Egypt Precision Medicine Market, by Patient Involvement, 2019-2032 (US$ Mn)
TABLE 560 Egypt Precision Medicine Market, by Patient Involvement, 2024-2032 (US$ Mn)
TABLE 561 Rest of Africa Precision Medicine Market, by Diagnostics, 2019-2032 (US$ Mn)
TABLE 562 Rest of Africa Precision Medicine Market, by Diagnostics, 2024-2032 (US$ Mn)
TABLE 563 Rest of Africa Precision Medicine Market, By Therapeutics, 2019-2032 (US$ Mn)
TABLE 564 Rest of Africa Precision Medicine Market, By Therapeutics, 2024-2032 (US$ Mn)
TABLE 565 Rest of Africa Precision Medicine Market, by Technology, 2019-2032 (US$ Mn)
TABLE 566 Rest of Africa Precision Medicine Market, by Technology, 2024-2032 (US$ Mn)
TABLE 567 Rest of Africa Precision Medicine Market, by Application, By Region, 2019-2032 (US$ Mn)
TABLE 568 Rest of Africa Precision Medicine Market, by Application, By Region, 2024-2032 (US$ Mn)
TABLE 569 Rest of Africa Precision Medicine Market, By End-User, 2019-2032 (US$ Mn)
TABLE 570 Rest of Africa Precision Medicine Market, By End-User, 2024-2032 (US$ Mn)
TABLE 571 Rest of Africa Precision Medicine Market, by Mode of Action, 2019-2032 (US$ Mn)
TABLE 572 Rest of Africa Precision Medicine Market, by Mode of Action, 2024-2032 (US$ Mn)
TABLE 573 Rest of Africa Precision Medicine Market, by Data Source, 2019-2032 (US$ Mn)
TABLE 574 Rest of Africa Precision Medicine Market, by Data Source, 2024-2032 (US$ Mn)
TABLE 575 Rest of Africa Precision Medicine Market, by Patient Involvement, 2019-2032 (US$ Mn)
TABLE 576 Rest of Africa Precision Medicine Market, by Patient Involvement, 2024-2032 (US$ Mn)

Frequently Asked Questions

What is the current Product Type of the global Precision Medicine Market?

The global Precision Medicine Market was valued at USD 28915.2 million in 2023.

What is the expected growth rate of the Precision Medicine Market between 2024 and 2032?

The Precision Medicine Market is expected to grow at a CAGR of 13.20% between 2024 and 2032, reaching USD 88255.9 million in 2032.

Which segment is leading the market share in terms of Application?

In 2023, the oncology application dominated the global precision medicine market in terms of revenue share

Which End-User segment governs the demand for rapid pharmaceutical microbiology testing in the world?

Research Institutions are another high-demand sector in the precision medicine market.

Who are the major players in the global Precision Medicine Market?

The top players include Biocrates Life Sciences, TepnelPharma Services, Novartis, Qiagen, Quest Diagnostics and Others

Trigeminal Neuralgia Treatment Market

Published:
Report ID: 11788

Pompe Disease Therapeutics Market

Published:
Report ID: 5989

Pre-Menstrual Syndrome Treatment Market

Published:
Report ID: 11248

Vial Adaptors for Reconstitution Drug Market

Published:
Report ID: 15561

Psychedelic Medicine Market

Published:
Report ID: 41606

Hospital Infection Prevention And Control Market

Published:
Report ID: 7217

Nanoparticle Formulation Market

Published:
Report ID: 41106

Animal Drug Compounding Market

Published:
Report ID: 40870

Antibiotics Market

Published:
Report ID: 40728

Conjugation and Labeling Services Market

Published:
Report ID: 40756

Antiviral Drugs Market

Published:
Report ID: 40681

Intravitreal Injectable Market

Published:
Report ID: 7250

Purchase Options

$2999
Delivery Format: Excel.
$4999
Designed for the individual purchaser.
$6999
Users located at a single corporate site or regional office.
$7999
Allowed for unlimited sharing globally within one company.
Smallform of Sample request

Have a question?

User Profile

Don’t settle for less – trust Mitul to help you find the best solution.

Report delivery within 24 to 48 hours

– Other Info –

What people say?-

User Review

I am very impressed with the information in this report. The author clearly did their research when they came up with this product and it has already given me a lot of ideas.

Jana Schmidt
CEDAR CX Technologies

– Connect with us –

Phone

+91 6232 49 3207


support

24/7 Research Support


sales@credenceresearch.com

– Research Methodology –

Going beyond the basics: advanced techniques in research methodology

– Trusted By –

Pepshi, LG, Nestle
Motorola, Honeywell, Johnson and johnson
LG Chem, SIEMENS, Pfizer
Unilever, Samsonite, QIAGEN